| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ATXN2L ILK CD2AP OBSCN STK38 UNC45A ITGA7 ITGAD ITGAM PTPN2 NLGN3 KIRREL3 NEO1 PTPN11 DST PTPRD AHNAK AFDN TLN2 GPNMB GCN1 NOS2 GOLGA3 VCL FLNA FLNB ANK3 DSCAM DSP TNC ADAMTS8 GRIN2B AHSA1 CTNNA3 GIGYF2 TNKS1BP1 MARK2 TNXB CDH11 | 5.46e-13 | 599 | 337 | 39 | GO:0050839 |
| GeneOntologyMolecularFunction | cadherin binding | ATXN2L CD2AP OBSCN STK38 UNC45A NEO1 PTPN11 AHNAK AFDN GCN1 NOS2 GOLGA3 VCL FLNA FLNB ANK3 AHSA1 CTNNA3 GIGYF2 TNKS1BP1 MARK2 CDH11 | 8.17e-08 | 339 | 337 | 22 | GO:0045296 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | CD2AP TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A TLN2 ANK3 DSP TUBA3D TUBA1C ARPC2 | 2.13e-06 | 130 | 337 | 12 | GO:0005200 |
| GeneOntologyMolecularFunction | integrin binding | 1.97e-04 | 175 | 337 | 11 | GO:0005178 | |
| GeneOntologyMolecularFunction | actin binding | CD2AP TMOD2 RUSC1 NEB JMY DST AFDN TLN2 CORO7 NOS2 VCL FKBP15 FLNA FLNB FLNC SORBS1 ARPC2 SYNE3 SIPA1L1 CTNNA3 | 2.01e-04 | 479 | 337 | 20 | GO:0003779 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CYLD DCHS2 RIPOR2 ADAM19 ILK NEXMIF CD2AP ITGA7 ITGAD ITGAM TESPA1 PTPN2 NLGN3 KIRREL3 NEO1 FAT2 PTPN11 PTPRD PCDH11X COL14A1 AFDN TLN2 GPNMB PCDH18 VCL FLNA FAT4 HTR2A ANK3 DSCAM DSP FAT3 AKNA EPB41L5 LAMA3 PCDHAC2 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 CTNNA3 CARD11 SIGLEC1 TNXB CDH11 IL7R NCKAP1L | 3.07e-10 | 1077 | 339 | 48 | GO:0098609 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 KIRREL3 FAT2 PCDH11X PCDH18 FAT4 DSCAM FAT3 PCDHAC2 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 CDH11 | 5.08e-07 | 187 | 339 | 15 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 ASXL1 RIPOR2 SPAST ILK TRIO CD2AP DPYSL5 ITGA7 ADARB1 BDNF NLGN3 KIRREL3 NEO1 PTPN11 KANK1 DST PTPRD TUBA1A NGF AFDN NOTCH2 VCL FLNA FLNB ANK3 DSCAM FAT3 EPB41L5 LAMA3 PCDHAC2 CRPPA SPAG6 WDR19 SYNE3 SIPA1L1 MARK2 CDH11 ZMYM3 IL7R NCKAP1L | 6.62e-06 | 1194 | 339 | 41 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | ILK NEXMIF THSD1 ACVRL1 ITGA7 ITGAD ITGAM FAT2 PTPN11 KANK1 VCL FLNA EPB41L5 SORBS1 SPAG6 ARPC2 SNED1 SIGLEC1 TNXB CDH11 | 1.65e-05 | 410 | 339 | 20 | GO:0031589 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 ITGAM KIRREL3 FAT2 PTPRD PCDH11X PCDH18 FAT4 DSCAM FAT3 PCDHAC2 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 CDH11 | 1.85e-05 | 313 | 339 | 17 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 CACNA2D2 CD2AP STK38 THSD1 ACVRL1 ITGAM ZDHHC8 BDNF NLGN3 KIRREL3 PTPN11 DST PTPRD TUBA1A GPR158 AJM1 AFDN TLN2 BSN VCL FLNA ANK3 DSCAM DSP TNC EPB41L5 LAMA3 SORBS1 GRIN2B SHANK2 SIPA1L1 MARK2 CDH11 | 3.08e-05 | 974 | 339 | 34 | GO:0034330 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 SPAST ILK TRIO CD2AP DPYSL5 ADARB1 BDNF NLGN3 KIRREL3 NEO1 PTPN11 KANK1 DST PTPRD TUBA1A NGF AFDN NOTCH2 VCL ANK3 DSCAM LAMA3 PCDHAC2 CRPPA SPAG6 SIPA1L1 MARK2 CDH11 NCKAP1L | 3.85e-05 | 819 | 339 | 30 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | ILK NEXMIF THSD1 ACVRL1 ITGA7 ITGAD ITGAM PTPN11 VCL EPB41L5 SORBS1 SNED1 SIGLEC1 TNXB CDH11 | 4.42e-05 | 270 | 339 | 15 | GO:0007160 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 SPAST ILK TRIO CD2AP DPYSL5 ADARB1 BDNF NLGN3 KIRREL3 NEO1 PTPN11 KANK1 DST PTPRD TUBA1A NGF AFDN NOTCH2 VCL ANK3 DSCAM LAMA3 PCDHAC2 CRPPA SPAG6 SIPA1L1 MARK2 CDH11 NCKAP1L | 4.50e-05 | 826 | 339 | 30 | GO:0048858 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CYLD RIPOR2 SPAST PARD6G TUBA3E TUBA4A TUBA3C TUBA1B DST TUBA1A CLTC CAMSAP2 FLNA DCAF13 ANK3 TUBA3D TUBA1C RANBP9 PRC1 NCKAP5L SPAG6 CDC14A NCOR1 SMC3 MARK4 CCDC120 MARK2 | 6.41e-05 | 720 | 339 | 27 | GO:0000226 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TANC2 SPAST ILK TRIO CD2AP DPYSL5 ADARB1 BDNF NLGN3 KIRREL3 NEO1 PTPN11 DST PTPRD TUBA1A NGF AFDN NOTCH2 VCL ANK3 DSCAM LAMA3 PCDHAC2 CRPPA SPAG6 SIPA1L1 MARK2 CDH11 NCKAP1L | 6.53e-05 | 802 | 339 | 29 | GO:0048812 |
| GeneOntologyBiologicalProcess | axon development | SPAST ILK TRIO CD2AP DPYSL5 ADARB1 BDNF NLGN3 NEO1 PTPN11 DST NGF CAMSAP2 NOTCH2 VCL FLNA ANK3 DSCAM TNC LAMA3 PCDHAC2 CRPPA SIPA1L1 MARK2 CDH11 | 6.62e-05 | 642 | 339 | 25 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 7.38e-05 | 108 | 339 | 9 | GO:0007044 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte communication | 8.48e-05 | 15 | 339 | 4 | GO:0086069 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | CYLD TRPM4 RIPOR2 TRH CACNA2D2 CD2AP CFTR ITGAM ZDHHC8 BDNF NLGN3 FNDC1 NEO1 PTPN11 RPTOR CLTC AFDN TMEM97 NOS1 NOS2 VCL FLNA POLR1A ANK3 UACA STXBP5L EPB41L5 SORBS1 SIRT6 ARPC2 PIM3 MIDN TRIM28 MARK4 EDEM1 | 1.18e-04 | 1087 | 339 | 35 | GO:0032880 |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 1.20e-04 | 115 | 339 | 9 | GO:0150115 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 RIPOR2 SPAST ILK TRIO CD2AP DPYSL5 ADARB1 BDNF NLGN3 NEO1 PTPN11 DST PTPRD NGF AFDN NOTCH2 VCL ANK3 DSCAM FAT3 LAMA3 PCDHAC2 CRPPA SIPA1L1 MARK2 CDH11 | 1.20e-04 | 748 | 339 | 27 | GO:0048667 |
| GeneOntologyBiologicalProcess | actin polymerization-dependent cell motility | 1.47e-04 | 7 | 339 | 3 | GO:0070358 | |
| GeneOntologyBiologicalProcess | axonogenesis | SPAST ILK TRIO CD2AP DPYSL5 ADARB1 BDNF NLGN3 NEO1 PTPN11 DST NGF NOTCH2 VCL ANK3 DSCAM LAMA3 PCDHAC2 CRPPA SIPA1L1 MARK2 CDH11 | 1.86e-04 | 566 | 339 | 22 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | CYLD TRPM4 RIPOR2 TRH CACNA2D2 TRPC3 CD2AP CFTR PARD6G ITGAM ZDHHC8 BDNF NLGN3 FNDC1 NEO1 PTPN11 RPTOR CLTC AFDN TMEM97 NOS1 NOS2 VCL FLNA POLR1A ANK3 UACA STXBP5L EPB41L5 SORBS1 SIRT6 ARPC2 PIM3 MIDN TRIM28 MARK4 EDEM1 | 2.18e-04 | 1212 | 339 | 37 | GO:0060341 |
| GeneOntologyCellularComponent | supramolecular fiber | CYLD SPAST ILK DCDC1 KRT74 CD2AP OBSCN TMOD2 RUSC1 TUBA3E NEB TUBA4A TUBA3C TUBA1B DST TUBA1A AHNAK CLTC CAMSAP2 DNAH6 NOS1 MTUS2 VCL FLNA FLNB FLNC HTR2A ANK3 DSP TUBA3D TUBA1C AKNA GRIN2B PRC1 NCKAP5L SPAG6 ARPC2 SHANK2 TMEM232 MARK2 | 9.69e-06 | 1179 | 341 | 40 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CYLD SPAST ILK DCDC1 KRT74 CD2AP OBSCN TMOD2 RUSC1 TUBA3E NEB TUBA4A TUBA3C TUBA1B DST TUBA1A AHNAK CLTC CAMSAP2 DNAH6 NOS1 MTUS2 VCL FLNA FLNB FLNC HTR2A ANK3 DSP TUBA3D TUBA1C AKNA GRIN2B PRC1 NCKAP5L SPAG6 ARPC2 SHANK2 TMEM232 MARK2 | 1.13e-05 | 1187 | 341 | 40 | GO:0099081 |
| GeneOntologyCellularComponent | cell-cell contact zone | 2.32e-05 | 94 | 341 | 9 | GO:0044291 | |
| GeneOntologyCellularComponent | costamere | 2.35e-05 | 22 | 341 | 5 | GO:0043034 | |
| GeneOntologyCellularComponent | dendrite | TANC2 ILK CD2AP CFTR DPYSL5 ACVRL1 BDNF GPR179 NLGN3 KIRREL3 RPTOR PURA NGF C4B BSN NOS1 DAGLA FLNA HTR2A ANK3 DSCAM FAT3 GRIN2B ARPC2 SHANK2 TP63 SIPA1L1 MARK4 GIGYF2 ABHD13 MARK2 | 3.22e-05 | 858 | 341 | 31 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 ILK CD2AP CFTR DPYSL5 ACVRL1 BDNF GPR179 NLGN3 KIRREL3 RPTOR PURA NGF C4B BSN NOS1 DAGLA FLNA HTR2A ANK3 DSCAM FAT3 GRIN2B ARPC2 SHANK2 TP63 SIPA1L1 MARK4 GIGYF2 ABHD13 MARK2 | 3.36e-05 | 860 | 341 | 31 | GO:0097447 |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 ILK CD2AP OBSCN PARD6G KIRREL3 FNDC1 FAT2 DST AJM1 AHNAK AFDN TLN2 VCL USP53 FLNA ANK3 DSP EPB41L5 LAMA3 SORBS1 CTNNA3 TNKS1BP1 CDH11 | 4.31e-05 | 591 | 341 | 24 | GO:0005911 |
| GeneOntologyCellularComponent | fascia adherens | 4.43e-05 | 13 | 341 | 4 | GO:0005916 | |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 TRPM4 ILK CD2AP CFTR NAIP DPYSL5 ACVRL1 HNRNPA2B1 BDNF GPR179 NLGN3 KIRREL3 NEO1 RPTOR PURA NGF AFDN C4B BSN NOS1 DAGLA FLNA FLNB HTR2A ANK3 DSCAM FAT3 GRIN2B ARPC2 SHANK2 TP63 SIPA1L1 MARK4 GIGYF2 ABHD13 WDFY3 MARK2 | 1.17e-04 | 1228 | 341 | 38 | GO:0036477 |
| GeneOntologyCellularComponent | intercalated disc | 1.19e-04 | 68 | 341 | 7 | GO:0014704 | |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 ILK CD2AP OBSCN PARD6G THSD1 ITGA7 KIRREL3 FNDC1 FAT2 DST AJM1 AHNAK CLTC AFDN TLN2 VCL USP53 FLNA FLNB FLNC ANK3 DSP TNC EPB41L5 LAMA3 SORBS1 ARPC2 CTNNA3 TNKS1BP1 RPL5 CDH11 | 1.48e-04 | 976 | 341 | 32 | GO:0070161 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | CYLD SPAST DCDC1 KRT74 CD2AP RUSC1 TUBA3E TUBA4A TUBA3C TUBA1B DST TUBA1A CLTC CAMSAP2 DNAH6 MTUS2 VCL FLNA HTR2A DSP TUBA3D TUBA1C AKNA PRC1 NCKAP5L SPAG6 ARPC2 SHANK2 TMEM232 MARK2 | 1.77e-04 | 899 | 341 | 30 | GO:0099513 |
| GeneOntologyCellularComponent | Z disc | 1.92e-04 | 151 | 341 | 10 | GO:0030018 | |
| GeneOntologyCellularComponent | podosome ring | 2.65e-04 | 2 | 341 | 2 | GO:0061826 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | TANC2 RUSC1 HNRNPA2B1 BDNF NLGN3 NEO1 DST PTPRD GPR158 PURA AFDN BSN MAP3K7 NOS1 DAGLA ANK3 GRIN2B SHANK2 SIPA1L1 RPL5 | 4.06e-04 | 523 | 341 | 20 | GO:0098984 |
| GeneOntologyCellularComponent | I band | 4.11e-04 | 166 | 341 | 10 | GO:0031674 | |
| GeneOntologyCellularComponent | microtubule | CYLD SPAST DCDC1 RUSC1 TUBA3E TUBA4A TUBA3C TUBA1B DST TUBA1A CLTC CAMSAP2 DNAH6 MTUS2 TUBA3D TUBA1C AKNA PRC1 NCKAP5L SPAG6 | 5.16e-04 | 533 | 341 | 20 | GO:0005874 |
| GeneOntologyCellularComponent | myofibril | ILK OBSCN TMOD2 NEB DST AHNAK NOS1 VCL FLNA FLNB FLNC ANK3 GRIN2B | 5.82e-04 | 273 | 341 | 13 | GO:0030016 |
| GeneOntologyCellularComponent | axon | TANC2 SPAST ILK CD2AP TMOD2 BDNF KIRREL3 NEO1 DST NGF AFDN C4B BSN NOS1 DAGLA SLC12A6 FKBP15 FLNA HTR2A ANK3 DSCAM GRIN2B ARPC2 SHANK2 LGI3 AP3B2 CCDC120 WDFY3 | 7.48e-04 | 891 | 341 | 28 | GO:0030424 |
| GeneOntologyCellularComponent | adherens junction | FAT2 AJM1 AFDN VCL DSP EPB41L5 LAMA3 SORBS1 CTNNA3 TNKS1BP1 CDH11 | 7.56e-04 | 212 | 341 | 11 | GO:0005912 |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 7.79e-04 | 67 | 341 | 6 | GO:0098686 | |
| GeneOntologyCellularComponent | sarcomere | 8.46e-04 | 249 | 341 | 12 | GO:0030017 | |
| GeneOntologyCellularComponent | asymmetric synapse | TANC2 RUSC1 HNRNPA2B1 NLGN3 NEO1 DST GPR158 PURA AFDN BSN MAP3K7 NOS1 DAGLA ANK3 GRIN2B SHANK2 SIPA1L1 RPL5 | 9.11e-04 | 477 | 341 | 18 | GO:0032279 |
| GeneOntologyCellularComponent | contractile muscle fiber | ILK OBSCN TMOD2 NEB DST AHNAK NOS1 VCL FLNA FLNB FLNC ANK3 GRIN2B | 1.02e-03 | 290 | 341 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | cell-substrate junction | ILK THSD1 ITGA7 DST AHNAK CLTC TLN2 VCL FLNA FLNB FLNC TNC EPB41L5 LAMA3 SORBS1 ARPC2 RPL5 | 1.05e-03 | 443 | 341 | 17 | GO:0030055 |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 RUSC1 HNRNPA2B1 NEO1 DST GPR158 PURA AFDN BSN MAP3K7 NOS1 DAGLA ANK3 GRIN2B SHANK2 SIPA1L1 RPL5 | 1.27e-03 | 451 | 341 | 17 | GO:0014069 |
| GeneOntologyCellularComponent | tenascin complex | 1.56e-03 | 4 | 341 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | Myb complex | 1.56e-03 | 4 | 341 | 2 | GO:0031523 | |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 RUSC1 HNRNPA2B1 NLGN3 NEO1 DST GPR158 PURA AFDN BSN MAP3K7 NOS1 DAGLA ANK3 GRIN2B SHANK2 SIPA1L1 RPL5 | 1.65e-03 | 503 | 341 | 18 | GO:0099572 |
| GeneOntologyCellularComponent | Golgi lumen | 2.08e-03 | 109 | 341 | 7 | GO:0005796 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 2.19e-03 | 110 | 341 | 7 | GO:0120111 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.73e-03 | 59 | 341 | 5 | GO:0098636 | |
| MousePheno | abnormal neurite morphology | SPAST CACNA2D2 NEXMIF TRPC3 DPYSL5 CSMD3 ZDHHC8 BDNF DST TUBA1A GPR158 PURA CAMSAP2 ZBTB18 NOS1 SLC12A6 VRK2 ADAP1 DSCAM GRIN2B SHANK2 SMC3 LGI3 MBD5 | 3.74e-06 | 442 | 265 | 24 | MP:0008415 |
| MousePheno | decreased total body fat amount | UBR1 FBXW10B CACNA2D2 RUSC1 NEB CSMD3 PHF2 PTPN2 PTPN11 PTPRD AHNAK CRYBG1 PCDH18 CRTC3 FBXW10 KIAA1549 SIRT6 SLC3A1 ARPC2 NCOR1 SMC3 EIF4EBP1 MARK4 EDEM1 | 1.26e-05 | 475 | 265 | 24 | MP:0010025 |
| MousePheno | abnormal pyramidal neuron dendrite morphology | 2.89e-05 | 20 | 265 | 5 | MP:0020337 | |
| MousePheno | abnormal dendrite morphology | NEXMIF TRPC3 DPYSL5 CSMD3 ZDHHC8 BDNF TUBA1A GPR158 CAMSAP2 NOS1 VRK2 ADAP1 GRIN2B SHANK2 SMC3 | 4.71e-05 | 237 | 265 | 15 | MP:0008143 |
| MousePheno | abnormal dendritic spine morphology | NEXMIF CSMD3 ZDHHC8 BDNF GPR158 VRK2 ADAP1 GRIN2B SHANK2 SMC3 | 6.57e-05 | 115 | 265 | 10 | MP:0009936 |
| Domain | Alpha_tubulin | 2.47e-09 | 9 | 333 | 6 | IPR002452 | |
| Domain | Cadherin_CS | DCHS2 FAT2 PCDH11X PCDH18 FAT4 FAT3 PCDHAC2 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 CDH11 | 7.32e-08 | 109 | 333 | 13 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 FAT2 PCDH11X PCDH18 FAT4 FAT3 PCDHAC2 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 CDH11 | 1.13e-07 | 113 | 333 | 13 | PS00232 |
| Domain | Cadherin | DCHS2 FAT2 PCDH11X PCDH18 FAT4 FAT3 PCDHAC2 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 CDH11 | 1.13e-07 | 113 | 333 | 13 | PF00028 |
| Domain | - | DCHS2 FAT2 PCDH11X PCDH18 FAT4 FAT3 PCDHAC2 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 CDH11 | 1.25e-07 | 114 | 333 | 13 | 2.60.40.60 |
| Domain | CADHERIN_2 | DCHS2 FAT2 PCDH11X PCDH18 FAT4 FAT3 PCDHAC2 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 CDH11 | 1.25e-07 | 114 | 333 | 13 | PS50268 |
| Domain | CA | DCHS2 FAT2 PCDH11X PCDH18 FAT4 FAT3 PCDHAC2 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 CDH11 | 1.39e-07 | 115 | 333 | 13 | SM00112 |
| Domain | Cadherin-like | DCHS2 FAT2 PCDH11X PCDH18 FAT4 FAT3 PCDHAC2 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 CDH11 | 1.54e-07 | 116 | 333 | 13 | IPR015919 |
| Domain | ANK_REP_REGION | TANC2 CDKN2C AGAP5 ILK TRPC3 AGAP11 ASAP2 KANK1 ASB9 ANKRD28 ANKRD52 NOTCH2 ANK3 UACA MUC16 YTHDC2 TNNI3K ANKRD60 AGAP9 | 1.62e-07 | 254 | 333 | 19 | PS50297 |
| Domain | Cadherin | DCHS2 FAT2 PCDH11X PCDH18 FAT4 FAT3 PCDHAC2 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 CDH11 | 1.89e-07 | 118 | 333 | 13 | IPR002126 |
| Domain | ANK_REPEAT | TANC2 CDKN2C AGAP5 ILK TRPC3 AGAP11 ASAP2 KANK1 ASB9 ANKRD28 ANKRD52 NOTCH2 ANK3 UACA MUC16 YTHDC2 TNNI3K ANKRD60 | 7.19e-07 | 253 | 333 | 18 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | TANC2 CDKN2C AGAP5 ILK TRPC3 AGAP11 ASAP2 KANK1 ASB9 ANKRD28 ANKRD52 NOTCH2 ANK3 UACA YTHDC2 TNNI3K ANKRD60 AGAP9 | 7.61e-07 | 254 | 333 | 18 | IPR020683 |
| Domain | - | 9.64e-07 | 20 | 333 | 6 | 3.30.1330.20 | |
| Domain | Ankyrin_rpt | TANC2 CDKN2C TRPM4 AGAP5 ILK TRPC3 AGAP11 ASAP2 KANK1 ASB9 ANKRD28 ANKRD52 NOTCH2 ANK3 UACA YTHDC2 TNNI3K ANKRD60 | 1.19e-06 | 262 | 333 | 18 | IPR002110 |
| Domain | - | 1.33e-06 | 21 | 333 | 6 | 1.10.287.600 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.80e-06 | 22 | 333 | 6 | IPR018316 | |
| Domain | - | 1.80e-06 | 22 | 333 | 6 | 3.40.50.1440 | |
| Domain | Tubulin_C | 1.80e-06 | 22 | 333 | 6 | SM00865 | |
| Domain | Tubulin_C | 1.80e-06 | 22 | 333 | 6 | PF03953 | |
| Domain | Tubulin_C | 2.40e-06 | 23 | 333 | 6 | IPR023123 | |
| Domain | TUBULIN | 2.40e-06 | 23 | 333 | 6 | PS00227 | |
| Domain | Tubulin | 2.40e-06 | 23 | 333 | 6 | SM00864 | |
| Domain | Tub_FtsZ_C | 2.40e-06 | 23 | 333 | 6 | IPR008280 | |
| Domain | Tubulin | 2.40e-06 | 23 | 333 | 6 | IPR000217 | |
| Domain | Tubulin_CS | 2.40e-06 | 23 | 333 | 6 | IPR017975 | |
| Domain | - | TANC2 CDKN2C AGAP5 ILK TRPC3 AGAP11 ASAP2 KANK1 ASB9 ANKRD28 ANKRD52 NOTCH2 ANK3 UACA YTHDC2 ANKRD60 AGAP9 | 2.44e-06 | 248 | 333 | 17 | 1.25.40.20 |
| Domain | ANK | TANC2 CDKN2C AGAP5 ILK TRPC3 AGAP11 ASAP2 KANK1 ASB9 ANKRD28 ANKRD52 NOTCH2 ANK3 UACA YTHDC2 TNNI3K ANKRD60 | 2.87e-06 | 251 | 333 | 17 | SM00248 |
| Domain | Tubulin_FtsZ_GTPase | 3.15e-06 | 24 | 333 | 6 | IPR003008 | |
| Domain | Tubulin | 3.15e-06 | 24 | 333 | 6 | PF00091 | |
| Domain | Ank | TANC2 CDKN2C ILK TRPC3 AGAP11 ASAP2 KANK1 ASB9 ANKRD28 ANKRD52 NOTCH2 ANK3 UACA TNNI3K ANKRD60 | 1.56e-05 | 228 | 333 | 15 | PF00023 |
| Domain | Cadherin_2 | 1.96e-05 | 65 | 333 | 8 | PF08266 | |
| Domain | Cadherin_N | 1.96e-05 | 65 | 333 | 8 | IPR013164 | |
| Domain | Ank_2 | TANC2 AGAP5 ILK TRPC3 AGAP11 ASAP2 KANK1 ASB9 ANKRD28 ANKRD52 NOTCH2 ANK3 UACA ANKRD60 | 3.35e-05 | 215 | 333 | 14 | PF12796 |
| Domain | Cadherin_tail | 4.48e-05 | 37 | 333 | 6 | PF15974 | |
| Domain | Cadherin_CBD | 4.48e-05 | 37 | 333 | 6 | IPR031904 | |
| Domain | ArfGap | 1.46e-04 | 29 | 333 | 5 | SM00105 | |
| Domain | ARFGAP | 1.46e-04 | 29 | 333 | 5 | PS50115 | |
| Domain | ArfGap | 1.46e-04 | 29 | 333 | 5 | PF01412 | |
| Domain | ArfGAP | 1.46e-04 | 29 | 333 | 5 | IPR001164 | |
| Domain | Ig-like_fold | TRIO OBSCN KIR2DS2 TGM6 KIRREL3 FNDC1 NEO1 PTPRD COL14A1 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1 EBF4 SIGLEC12 FLNA FLNB FLNC DSCAM TNC SNED1 SHANK2 IGKC SIGLEC1 TNXB IL7R | 1.73e-04 | 706 | 333 | 27 | IPR013783 |
| Domain | Vinculin/catenin | 1.86e-04 | 7 | 333 | 3 | IPR006077 | |
| Domain | - | 2.69e-04 | 71 | 333 | 7 | 1.10.418.10 | |
| Domain | NosD | 3.17e-04 | 2 | 333 | 2 | PF05048 | |
| Domain | Para_beta_helix_rpt-2 | 3.17e-04 | 2 | 333 | 2 | IPR022441 | |
| Domain | NosD_dom | 3.17e-04 | 2 | 333 | 2 | IPR007742 | |
| Domain | CH | 3.20e-04 | 73 | 333 | 7 | PS50021 | |
| Domain | - | TRIO OBSCN KIR2DS2 TGM6 KIRREL3 FNDC1 NEO1 PTPRD COL14A1 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1 EBF4 SIGLEC12 FLNA FLNB FLNC DSCAM TNC SNED1 SIGLEC1 TNXB IL7R | 3.72e-04 | 663 | 333 | 25 | 2.60.40.10 |
| Domain | CH-domain | 3.78e-04 | 75 | 333 | 7 | IPR001715 | |
| Domain | IG_FLMN | 6.14e-04 | 10 | 333 | 3 | SM00557 | |
| Domain | ig | OBSCN KIR2DS2 PTPRD KIR2DL3 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1 SIGLEC12 DSCAM SIGLEC1 | 6.28e-04 | 190 | 333 | 11 | PF00047 |
| Domain | Immunoglobulin | OBSCN KIR2DS2 PTPRD KIR2DL3 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1 SIGLEC12 DSCAM SIGLEC1 | 6.28e-04 | 190 | 333 | 11 | IPR013151 |
| Domain | fn3 | 6.71e-04 | 162 | 333 | 10 | PF00041 | |
| Domain | ACTININ_2 | 6.72e-04 | 23 | 333 | 4 | PS00020 | |
| Domain | ACTININ_1 | 6.72e-04 | 23 | 333 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 6.72e-04 | 23 | 333 | 4 | IPR001589 | |
| Domain | Filamin | 8.33e-04 | 11 | 333 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 8.33e-04 | 11 | 333 | 3 | PS50194 | |
| Domain | Filamin/ABP280_repeat-like | 8.33e-04 | 11 | 333 | 3 | IPR017868 | |
| Domain | Integrin_alpha | 8.33e-04 | 11 | 333 | 3 | PF00357 | |
| Domain | Filamin/ABP280_rpt | 8.33e-04 | 11 | 333 | 3 | IPR001298 | |
| Domain | NO_synthase | 9.40e-04 | 3 | 333 | 2 | PF02898 | |
| Domain | NOS_euk | 9.40e-04 | 3 | 333 | 2 | IPR012144 | |
| Domain | IP3R-bd | 9.40e-04 | 3 | 333 | 2 | IPR029325 | |
| Domain | NOS_N | 9.40e-04 | 3 | 333 | 2 | IPR004030 | |
| Domain | Carb-bd_sugar_hydrolysis-dom | 9.40e-04 | 3 | 333 | 2 | IPR006633 | |
| Domain | CASH | 9.40e-04 | 3 | 333 | 2 | SM00722 | |
| Domain | KRAP_IP3R_bind | 9.40e-04 | 3 | 333 | 2 | SM01257 | |
| Domain | - | 9.40e-04 | 3 | 333 | 2 | 3.90.340.10 | |
| Domain | KRAP_IP3R_bind | 9.40e-04 | 3 | 333 | 2 | PF14722 | |
| Domain | - | 9.40e-04 | 3 | 333 | 2 | 4.10.1130.10 | |
| Domain | NOS | 9.40e-04 | 3 | 333 | 2 | PS60001 | |
| Domain | CH | 1.05e-03 | 65 | 333 | 6 | SM00033 | |
| Domain | FN3_dom | OBSCN FNDC1 NEO1 PTPRD COL14A1 FLNC DSCAM TNC SNED1 TNXB IL7R | 1.37e-03 | 209 | 333 | 11 | IPR003961 |
| Domain | CH | 1.54e-03 | 70 | 333 | 6 | PF00307 | |
| Domain | Spectrin_repeat | 1.66e-03 | 29 | 333 | 4 | IPR002017 | |
| Domain | FN3 | 1.84e-03 | 185 | 333 | 10 | SM00060 | |
| Domain | NGF | 1.86e-03 | 4 | 333 | 2 | PF00243 | |
| Domain | NGF_1 | 1.86e-03 | 4 | 333 | 2 | PS00248 | |
| Domain | NGF | 1.86e-03 | 4 | 333 | 2 | SM00140 | |
| Domain | Nerve_growth_factor-rel | 1.86e-03 | 4 | 333 | 2 | PD002052 | |
| Domain | Haemoglobin_a-typ | 1.86e-03 | 4 | 333 | 2 | IPR002338 | |
| Domain | VINCULIN_1 | 1.86e-03 | 4 | 333 | 2 | PS00663 | |
| Domain | MARK/par1 | 1.86e-03 | 4 | 333 | 2 | IPR033624 | |
| Domain | Nerve_growth_factor-like | 1.86e-03 | 4 | 333 | 2 | IPR020408 | |
| Domain | Nerve_growth_factor_CS | 1.86e-03 | 4 | 333 | 2 | IPR019846 | |
| Domain | Vinculin_CS | 1.86e-03 | 4 | 333 | 2 | IPR000633 | |
| Domain | NGF_2 | 1.86e-03 | 4 | 333 | 2 | PS50270 | |
| Domain | Nerve_growth_factor-rel | 1.86e-03 | 4 | 333 | 2 | IPR002072 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 3.00e-09 | 23 | 246 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 7.58e-09 | 17 | 246 | 7 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.22e-08 | 18 | 246 | 7 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.91e-08 | 19 | 246 | 7 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.91e-08 | 19 | 246 | 7 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 2.89e-08 | 20 | 246 | 7 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 2.89e-08 | 20 | 246 | 7 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 4.27e-08 | 21 | 246 | 7 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 4.27e-08 | 21 | 246 | 7 | M47767 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 5.62e-08 | 32 | 246 | 8 | M29848 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 6.17e-08 | 22 | 246 | 7 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 8.74e-08 | 23 | 246 | 7 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 8.74e-08 | 23 | 246 | 7 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.22e-07 | 24 | 246 | 7 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.22e-07 | 24 | 246 | 7 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.66e-07 | 25 | 246 | 7 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.66e-07 | 25 | 246 | 7 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 2.24e-07 | 26 | 246 | 7 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.24e-07 | 26 | 246 | 7 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 3.92e-07 | 28 | 246 | 7 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 5.09e-07 | 29 | 246 | 7 | M27948 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 6.57e-07 | 43 | 246 | 8 | M47669 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 7.91e-07 | 44 | 246 | 8 | M27934 | |
| Pathway | REACTOME_AGGREPHAGY | 7.91e-07 | 44 | 246 | 8 | M29830 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 9.47e-07 | 45 | 246 | 8 | M47670 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.05e-06 | 32 | 246 | 7 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 1.31e-06 | 33 | 246 | 7 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 1.31e-06 | 33 | 246 | 7 | M47901 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.87e-06 | 49 | 246 | 8 | M891 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.01e-06 | 35 | 246 | 7 | M47774 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.56e-06 | 51 | 246 | 8 | M26972 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | ADAM19 ILK CD2AP PARD6G KIRREL3 PTPN11 DST TNRC6A AFDN FLNA FLNC LAMA3 CDH11 | 3.22e-06 | 155 | 246 | 13 | M522 |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.45e-06 | 53 | 246 | 8 | M27651 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 3.60e-06 | 38 | 246 | 7 | M14981 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 4.60e-06 | 55 | 246 | 8 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 5.29e-06 | 56 | 246 | 8 | M2333 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 5.78e-06 | 27 | 246 | 6 | MM15674 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 6.67e-06 | 76 | 246 | 9 | M27215 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 8.10e-06 | 17 | 246 | 5 | MM14731 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 8.53e-06 | 43 | 246 | 7 | M47773 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.36e-05 | 46 | 246 | 7 | M27828 | |
| Pathway | REACTOME_AGGREPHAGY | 3.34e-05 | 36 | 246 | 6 | MM15669 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 3.79e-05 | 117 | 246 | 10 | M19248 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 3.88e-05 | 73 | 246 | 8 | MM15126 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.92e-05 | 37 | 246 | 6 | MM15102 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 3.98e-05 | 54 | 246 | 7 | M27482 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 4.49e-05 | 96 | 246 | 9 | MM14592 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A CLTC ANK3 TUBA3D TUBA1C RANBP9 | 5.06e-05 | 121 | 246 | 10 | M872 |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 5.20e-05 | 76 | 246 | 8 | M48037 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 5.69e-05 | 57 | 246 | 7 | M27251 | |
| Pathway | REACTOME_KINESINS | 8.85e-05 | 61 | 246 | 7 | M977 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 9.16e-05 | 27 | 246 | 5 | MM15549 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | TUBA3E TUBA4A F8 TUBA3C TUBA1B TUBA1A SEC16A ANKRD28 ANK3 TUBA3D TUBA1C | 9.19e-05 | 156 | 246 | 11 | M27097 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.08e-04 | 44 | 246 | 6 | MM14606 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.31e-04 | 29 | 246 | 5 | MM15219 | |
| Pathway | KEGG_GAP_JUNCTION | 1.73e-04 | 90 | 246 | 8 | M4013 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.73e-04 | 90 | 246 | 8 | M29841 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.76e-04 | 48 | 246 | 6 | MM15353 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.77e-04 | 68 | 246 | 7 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.77e-04 | 68 | 246 | 7 | MM14968 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | ITGA7 ITGAD ITGAM FGF16 PIK3C2B RPTOR NGF FGF9 NOS1 NOS2 TNC LAMA3 HIF3A EIF4EBP1 TNXB IL7R | 1.99e-04 | 326 | 246 | 16 | MM15917 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.13e-04 | 32 | 246 | 5 | MM14730 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 2.33e-04 | 71 | 246 | 7 | M39690 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.35e-04 | 94 | 246 | 8 | M2843 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 2.54e-04 | 72 | 246 | 7 | M26954 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 2.76e-04 | 52 | 246 | 6 | MM15211 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | ITGA7 ITGAD FGF16 PIK3C2B RPTOR NGF FGF9 NOS1 NOS2 TNC LAMA3 HIF3A EIF4EBP1 TNXB IL7R | 2.77e-04 | 302 | 246 | 15 | M39719 |
| Pathway | REACTOME_PROTEIN_FOLDING | 3.12e-04 | 98 | 246 | 8 | M776 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | TUBA3E TUBA4A TUBA3C TUBA1B PTPN2 TUBA1A FLNA FLNB TUBA3D TUBA1C | 3.18e-04 | 151 | 246 | 10 | M550 |
| Pathway | BIOCARTA_MTA3_PATHWAY | 3.52e-04 | 20 | 246 | 4 | MM1383 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.84e-04 | 127 | 246 | 9 | M27181 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 4.10e-04 | 102 | 246 | 8 | M27648 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | TUBA3E TUBA4A F8 TUBA3C TUBA1B TUBA1A SEC16A ANKRD28 ANK3 TUBA3D TUBA1C | 4.47e-04 | 187 | 246 | 11 | M961 |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 4.51e-04 | 79 | 246 | 7 | M27743 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C NCOR1 TRIM28 | 7.04e-04 | 138 | 246 | 9 | M29805 |
| Pathway | WP_FOCAL_ADHESION | 7.52e-04 | 199 | 246 | 11 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.52e-04 | 199 | 246 | 11 | M7253 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 7.81e-04 | 11 | 246 | 3 | M48099 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 9.68e-04 | 44 | 246 | 5 | M875 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.01e-03 | 66 | 246 | 6 | MM17074 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 1.18e-03 | 68 | 246 | 6 | M39456 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.28e-03 | 94 | 246 | 7 | MM14515 | |
| Pathway | WP_MAPK_SIGNALING | CACNA2D2 BDNF FGF16 NGF PLA2G4A FGF9 MAP3K7 FLNA FLNB FLNC MKNK1 MAPK13 | 1.31e-03 | 246 | 246 | 12 | M39597 |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 1.31e-03 | 47 | 246 | 5 | M39531 | |
| Pathway | WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS | 1.32e-03 | 13 | 246 | 3 | M39894 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.36e-03 | 95 | 246 | 7 | M6729 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 1.52e-03 | 29 | 246 | 4 | M27528 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 1.52e-03 | 29 | 246 | 4 | MM15253 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.64e-03 | 126 | 246 | 8 | M705 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.70e-03 | 73 | 246 | 6 | MM15672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 1.74e-03 | 30 | 246 | 4 | M47724 | |
| Pathway | REACTOME_AUTOPHAGY | 1.83e-03 | 158 | 246 | 9 | M27935 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.83e-03 | 100 | 246 | 7 | M27650 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 1.83e-03 | 74 | 246 | 6 | M39857 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 1.97e-03 | 31 | 246 | 4 | M27529 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 1.97e-03 | 31 | 246 | 4 | MM15254 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 2.05e-03 | 102 | 246 | 7 | MM15830 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 2.05e-03 | 102 | 246 | 7 | M39577 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.07e-03 | 52 | 246 | 5 | MM14949 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | TRIO DPYSL5 TUBA4A TUBA1B PTPN11 TUBA1A CLTC DSCAM TUBA3D TUBA1C RANBP9 ARPC2 | 2.15e-03 | 261 | 246 | 12 | MM15676 |
| Pubmed | MTA2 TANC2 ATXN2L DDAH1 TRIO DPYSL5 TMOD2 TUBA4A HNRNPA2B1 JMY NLGN3 DST TUBA1A AJM1 RPTOR PURA CLTC SEC16A AFDN TLN2 C4B BSN CORO7 CAMSAP2 DNAH6 NOS1 DAGLA THRAP3 MTUS2 GOLGA3 VCL SLC12A6 FLNA FLNB FLNC SRSF5 ANK3 DSP TNC TUBA1C LARS1 KIAA1549 YTHDC2 SORBS1 GRIN2B VIRMA LRCH3 ARPC2 SHANK2 TRIM28 SIPA1L1 LGI3 AP3B2 TNKS1BP1 MARK2 RPL5 | 9.81e-19 | 1431 | 342 | 56 | 37142655 | |
| Pubmed | RIPOR2 NEB ASAP2 DST CLTC TNRC6A MAP3K7 ZBTB18 GCN1 USP53 FLNA FLNC CRTC3 VRK2 ANK3 DSP CCDC186 RANBP9 LAMA3 SORBS1 NCKAP5L MKNK1 SMC3 TRIM28 N4BP2 GIGYF2 MBD5 TXLNG | 9.02e-14 | 486 | 342 | 28 | 20936779 | |
| Pubmed | 2.96e-13 | 9 | 342 | 7 | 21167302 | ||
| Pubmed | TANC2 CYLD TRAF3 TRIO ZNF462 NLGN3 DST PTPRD GPR158 RPTOR PURA CLTC SEC16A ANKRD28 AFDN TLN2 BSN CAMSAP2 NOS1 THRAP3 GOLGA3 FKBP15 ANK3 DSCAM UACA RANBP9 SORBS1 GRIN2B VIRMA ARPC2 NCOR1 SHANK2 TRIM28 N4BP2 SIPA1L1 GIGYF2 WDFY3 CDH11 | 4.66e-13 | 963 | 342 | 38 | 28671696 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MTA2 UBR1 ILK UNC45A TUBA4A HNRNPA2B1 HNRNPH3 DST UTP15 RPTOR AHNAK RECQL4 CLTC SEC16A ALDH18A1 ANKRD28 AFDN CORO7 GCN1 ANKRD52 THRAP3 VCL FLNA FLNB FLNC DCAF13 POLR1A DSP POLR2B LARS1 RANBP9 EPB41L5 CHCHD6 IFI16 TOE1 LIG3 NOP14 SMC3 TRIM28 IGKC HLTF DDX20 WDFY3 RPL5 ZMYM3 | 1.08e-12 | 1353 | 342 | 45 | 29467282 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 CYLD ATXN2L SPAST ILK TRIO CD2AP DPYSL5 UNC45A RUSC2 DST PIK3C2B RPTOR AHNAK SEC16A AFDN CAMSAP2 NOTCH2 FAM110B USP53 CRTC3 DSP EPB41L5 XIAP SORBS1 NCKAP5L VIRMA CDC14A SAMD11 N4BP2 SIPA1L1 MARK4 GIGYF2 TNKS1BP1 MARK2 | 1.80e-12 | 861 | 342 | 35 | 36931259 |
| Pubmed | MTA2 ATXN2L DST UTP15 AHNAK CLTC SEC16A ALDH18A1 ANKRD28 AFDN GCN1 ANKRD52 VCL FLNA FLNB FLNC DCAF13 DDX31 POLR1A SRSF5 DSP TUBA1C YTHDC2 VIRMA NOP14 GIGYF2 TNKS1BP1 DDX20 RPL5 ZMYM3 | 3.75e-12 | 653 | 342 | 30 | 22586326 | |
| Pubmed | MON2 TANC2 CYLD ATXN2L SPAST TRIO AASDHPPT WASHC2A TUBA4A PTPN2 NEO1 GPR158 AJM1 RPTOR PURA CLTC TNRC6A ANKRD28 AFDN TLN2 BSN MAP3K7 CAMSAP2 GCN1 NOS1 HNRNPLL THRAP3 FKBP15 FLNA FLNB ANK3 DSP STXBP5L RANBP9 SORBS1 GRIN2B SHANK2 TRIM28 SIPA1L1 RPL5 | 4.17e-12 | 1139 | 342 | 40 | 36417873 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MTA2 ATXN2L RBMXL1 UNC45A TUBA4A HNRNPA2B1 HNRNPH3 TUBA1B DAP3 PTPN2 DST UTP15 AHNAK CLTC ALDH18A1 CRYBG1 THRAP3 FLNA FLNB DCAF13 UACA DSP TUBA1C POLR2B LARS1 LAMA3 YTHDC2 PRC1 IFI16 AHSA1 CWC22 VIRMA TOE1 LRCH3 ARPC2 NOP14 SMC3 TRIM28 SIPA1L1 TNKS1BP1 MARK2 RPL5 | 5.69e-12 | 1257 | 342 | 42 | 36526897 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MTA2 TRIO CACNA2D2 UNC45A HNRNPA2B1 HNRNPH3 PHF2 TUBA1B DAP3 PTPN11 UTP15 RPTOR CLTC ALDH18A1 AFDN TLN2 BSN GCN1 HNRNPLL THRAP3 VCL FLNA FLNB DCAF13 POLR1A SRSF5 DSP TUBA1C POLR2B DUT LARS1 XIAP YTHDC2 PRC1 AHSA1 CWC22 TOE1 ARPC2 LIG3 SMC3 TRIM28 GIGYF2 DDX20 GALNT5 RPL5 | 6.17e-12 | 1425 | 342 | 45 | 30948266 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 MTA2 CDKN2C TRAF3 DPYSL5 AASDHPPT UNC45A HNRNPA2B1 PTPN2 PTPN11 PTPRD SEC16A ANKRD28 AFDN CORO7 GCN1 ANKRD52 HNRNPLL VCL SEL1L FKBP15 FLNA FLNB FLNC SRSF5 RANBP9 EPB41L5 YTHDC2 PPEF1 NCKAP5L CDC14A SMC3 TRIM28 MARK2 EDEM1 RPL5 | 1.29e-11 | 974 | 342 | 36 | 28675297 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 MTA2 TANC2 TRPM4 GTPBP6 TRIO OBSCN DGKQ IRF5 WASHC2A ZDHHC8 EHBP1L1 DST PIK3C2B RPTOR AHNAK SEC16A TLN2 GCN1 NOTCH2 FLNA FLNC KHNYN ZBTB4 AKNA BTAF1 PIM3 NCOR1 SYNE3 SHANK2 TRIM28 FURIN MARK4 TNKS1BP1 WDFY3 MAPKBP1 SNAPC4 MBD5 | 2.76e-11 | 1105 | 342 | 38 | 35748872 |
| Pubmed | KIAA0408 ILK TRIO OBSCN GON4L NEB ZNF462 NEO1 PTPN11 DST CLTC MLF1 ANKRD28 COL14A1 MAP3K7 NOTCH2 VCL SLC12A6 FLNB FLNC UACA DSP SORBS1 NCOR1 ENO3 | 3.73e-11 | 497 | 342 | 25 | 23414517 | |
| Pubmed | ATXN2L HNRNPA2B1 HNRNPH3 TUBA1B TUBA1A CLTC SEC16A TNRC6A THRAP3 FLNA FLNB UACA TUBA1C POLR2B NOP14 SMC3 SIPA1L1 GIGYF2 MARK2 | 4.12e-11 | 274 | 342 | 19 | 34244482 | |
| Pubmed | ATXN2L STK38 HNRNPA2B1 HNRNPH3 TUBA1B PURA CLTC SEC16A ALDH18A1 MAP3K7 TASOR THRAP3 GOLGA3 FLNA FLNB FLNC DSP LARS1 RANBP9 YTHDC2 SMC3 TRIM28 N4BP2 GIGYF2 DDX20 RPL5 | 6.06e-11 | 551 | 342 | 26 | 34728620 | |
| Pubmed | MON2 CYLD ASXL1 RIPOR2 GON4L CSMD3 WASHC2A RUSC2 KIRREL3 KANK1 CLTC SEC16A CAMSAP2 FKBP15 KHNYN SORBS1 VIRMA SIPA1L1 MARK4 GIGYF2 MAPKBP1 ZMYM3 | 1.48e-10 | 407 | 342 | 22 | 12693553 | |
| Pubmed | 3.81e-10 | 19 | 342 | 7 | 15698476 | ||
| Pubmed | 3.81e-10 | 19 | 342 | 7 | 15691386 | ||
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 3.84e-10 | 11 | 342 | 6 | 19664392 | |
| Pubmed | 5.32e-10 | 6 | 342 | 5 | 20528243 | ||
| Pubmed | 5.32e-10 | 6 | 342 | 5 | 3785200 | ||
| Pubmed | 5.32e-10 | 6 | 342 | 5 | 17882223 | ||
| Pubmed | 7.61e-10 | 12 | 342 | 6 | 19936734 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 7.61e-10 | 12 | 342 | 6 | 19181658 | |
| Pubmed | 7.61e-10 | 12 | 342 | 6 | 20137308 | ||
| Pubmed | 7.61e-10 | 12 | 342 | 6 | 20371502 | ||
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | TRAF3 TUBA4A PTPN11 TUBA1A CLTC PLA2G4A BSN NOS1 NANOS1 GRIN2B SHANK2 | 8.98e-10 | 86 | 342 | 11 | 10862698 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 ATXN2L ADARB1 HNRNPA2B1 RPTOR CLTC SEC16A PLA2G4A AFDN TLN2 THRAP3 NOTCH2 FLNA SRSF5 UACA DSP YTHDC2 BTAF1 IFI16 VIRMA NCOR1 TRIM28 SIPA1L1 GIGYF2 TNKS1BP1 DDX20 MARK2 SNAPC4 ZMYM3 | 1.03e-09 | 774 | 342 | 29 | 15302935 |
| Pubmed | CYLD HNRNPA2B1 NEO1 DST AHNAK CLTC SEC16A TNRC6A ALDH18A1 ANKRD28 AFDN MAP3K7 TASOR GCN1 HNRNPLL THRAP3 GOLGA3 NOTCH2 FAT4 ANK3 DSCAM CCDC186 TUBA1C EPB41L5 MUC16 MAGEC3 NCOR1 FURIN STK33 | 1.12e-09 | 777 | 342 | 29 | 35844135 | |
| Pubmed | 1.26e-09 | 22 | 342 | 7 | 28117675 | ||
| Pubmed | 1.40e-09 | 13 | 342 | 6 | 19934297 | ||
| Pubmed | 1.40e-09 | 13 | 342 | 6 | 19120281 | ||
| Pubmed | 1.40e-09 | 13 | 342 | 6 | 18687225 | ||
| Pubmed | CD2AP RUSC1 UNC45A ZNF462 DST AHNAK SEC16A TNRC6A ANKRD28 TASOR GCN1 ANKRD52 GOLGA3 FLNA FLNB DSP NCOR1 N4BP2 GIGYF2 TNKS1BP1 ZMYM3 | 1.46e-09 | 418 | 342 | 21 | 34709266 | |
| Pubmed | PDE3A GON4L NEB ADARB1 FAT2 DST AHNAK CLTC THRAP3 FLNA FLNB DSP FAT3 XIAP VIRMA GIGYF2 | 1.78e-09 | 234 | 342 | 16 | 36243803 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MTA2 ATXN2L RBMXL1 UNC45A HNRNPA2B1 TUBA1B DST UTP15 AHNAK CLTC PPIL2 THRAP3 FLNA FLNB DCAF13 POLR1A UACA DSP POLR2B LARS1 EPB41L5 PRC1 IFI16 TOE1 LRCH3 ARPC2 TRMT2A SMC3 TRIM28 DDX20 MARK2 RPL5 | 1.80e-09 | 949 | 342 | 32 | 36574265 |
| Pubmed | 1.85e-09 | 7 | 342 | 5 | 9430220 | ||
| Pubmed | AGAP5 TRAF3 CFTR AGAP11 STOX1 NLGN3 RPTOR PURA CAMSAP2 DAGLA VCL TNC KIAA1549 SORBS1 ARPC2 SIPA1L1 AP3B2 MARK4 CTNNA3 MARK2 AGAP9 | 2.41e-09 | 430 | 342 | 21 | 32581705 | |
| Pubmed | 2.43e-09 | 14 | 342 | 6 | 19875891 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | 2.43e-09 | 14 | 342 | 6 | 19421224 | |
| Pubmed | 2.43e-09 | 14 | 342 | 6 | 19489269 | ||
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 2.43e-09 | 14 | 342 | 6 | 15896204 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ATXN2L CD2AP STK38 UNC45A EHBP1L1 DST AHNAK CRYBG1 AFDN GCN1 GOLGA3 NOTCH2 VCL FLNA FLNB ANK3 UACA SORBS1 AHSA1 SHANK2 GIGYF2 CCDC120 TNKS1BP1 MARK2 | 2.70e-09 | 565 | 342 | 24 | 25468996 |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | TANC2 CYLD ATXN2L STK38 TUBA4A HNRNPA2B1 HNRNPH3 TUBA1B CLTC SEC16A MAP3K7 THRAP3 GOLGA3 FLNC TNIP2 TUBA1C AKNA TRIM28 RPL5 | 2.91e-09 | 353 | 342 | 19 | 27545878 |
| Pubmed | UBR1 ATXN2L UNC45A TUBA4A HNRNPA2B1 HNRNPH3 KANK1 TUBA1A CLTC SEC16A ALDH18A1 ANKRD28 PPIL2 MAP3K7 CAMSAP2 GCN1 HNRNPLL THRAP3 VCL FLNA SRSF5 UACA POLR2B LARS1 RANBP9 FBXO11 AHSA1 ARPC2 NCOR1 LIG3 SMC3 TRIM28 SIPA1L1 CCDC120 TNKS1BP1 MARK2 RPL5 | 2.93e-09 | 1247 | 342 | 37 | 27684187 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MTA2 RBMXL1 DPYSL5 STK38 USP9Y HNRNPA2B1 HNRNPH3 ZNF462 PHF2 DAP3 EHBP1L1 DST TUBA1A CLTC PPIL2 GCN1 HNRNPLL THRAP3 FKBP15 FLNC SRSF5 DSP POLR2B FBXO11 PCDHA1 CWC22 TOE1 LIG3 NOP14 TRIM28 TNKS1BP1 TNXB RPL5 ZMYM3 | 3.25e-09 | 1082 | 342 | 34 | 38697112 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | AGAP5 TRIO AGAP11 NLGN3 ASAP2 AHNAK PURA CLTC PIP5KL1 TLN2 ANK3 CHCHD6 SORBS1 GRIN2B SHANK2 SIPA1L1 AGAP9 | 3.53e-09 | 281 | 342 | 17 | 28706196 |
| Pubmed | 4.02e-09 | 15 | 342 | 6 | 20082646 | ||
| Pubmed | 4.02e-09 | 15 | 342 | 6 | 19850842 | ||
| Pubmed | 4.02e-09 | 15 | 342 | 6 | 20356536 | ||
| Pubmed | 4.02e-09 | 15 | 342 | 6 | 19793892 | ||
| Pubmed | 4.02e-09 | 15 | 342 | 6 | 19926642 | ||
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | 4.02e-09 | 15 | 342 | 6 | 20207982 | |
| Pubmed | 4.02e-09 | 15 | 342 | 6 | 19493232 | ||
| Pubmed | 4.02e-09 | 15 | 342 | 6 | 15640798 | ||
| Pubmed | 4.02e-09 | 15 | 342 | 6 | 20643584 | ||
| Pubmed | 4.02e-09 | 15 | 342 | 6 | 19326408 | ||
| Pubmed | TRIO TUBA4A TUBA1B ASAP2 DST TUBA1A AHNAK CLTC AFDN GCN1 THRAP3 DSP TUBA1C CWC22 SLC3A1 TRIM28 IGKC | 4.14e-09 | 284 | 342 | 17 | 29459677 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MTA2 ATXN2L CD2AP STK38 UNC45A TUBA4A HNRNPA2B1 TUBA1B PHKA2 DAP3 DST AHNAK CLTC SEC16A AFDN MAP3K7 GCN1 VCL FLNA FLNB FLNC SRSF5 ANK3 DSP TUBA1C KHNYN POLR2B LARS1 RANBP9 AHSA1 LIG3 SMC3 TRIM28 DDX20 RPL5 | 4.16e-09 | 1149 | 342 | 35 | 35446349 |
| Pubmed | TANC2 CYLD DST SEC16A TNRC6A ALDH18A1 ANKRD28 AFDN ANKRD52 NOTCH2 FKBP15 CRTC3 KIAA1549 SORBS1 NCKAP5L LRCH3 SMC3 SIPA1L1 EIF4EBP1 GIGYF2 MARK2 | 4.58e-09 | 446 | 342 | 21 | 24255178 | |
| Pubmed | 4.88e-09 | 8 | 342 | 5 | 9430221 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 4.88e-09 | 8 | 342 | 5 | 16148047 | |
| Pubmed | 6.38e-09 | 16 | 342 | 6 | 19897003 | ||
| Pubmed | 6.38e-09 | 16 | 342 | 6 | 19309280 | ||
| Pubmed | 6.38e-09 | 16 | 342 | 6 | 20652381 | ||
| Pubmed | 6.38e-09 | 16 | 342 | 6 | 17868255 | ||
| Pubmed | 6.38e-09 | 16 | 342 | 6 | 20331834 | ||
| Pubmed | 6.38e-09 | 16 | 342 | 6 | 19000141 | ||
| Pubmed | 6.38e-09 | 16 | 342 | 6 | 20670355 | ||
| Pubmed | 6.38e-09 | 16 | 342 | 6 | 18668235 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 6.38e-09 | 16 | 342 | 6 | 19527230 | |
| Pubmed | 6.38e-09 | 16 | 342 | 6 | 19279038 | ||
| Pubmed | 6.38e-09 | 16 | 342 | 6 | 18643961 | ||
| Pubmed | 6.38e-09 | 16 | 342 | 6 | 20210919 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | ATXN2L CD2AP STK38 UNC45A TUBA4A TUBA1A AHNAK CLTC SEC16A PLA2G4A GCN1 FLNA FLNB DSP GIGYF2 TNKS1BP1 | 6.46e-09 | 256 | 342 | 16 | 33397691 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | MTA2 ILK TUBA4A HNRNPA2B1 TUBA1B AHNAK CLTC GCN1 HNRNPLL FLNA FLNB TUBA1C LARS1 PRC1 NCOR1 SMC3 TRIM28 ZMYM3 | 6.82e-09 | 332 | 342 | 18 | 32786267 |
| Pubmed | CYLD ASXL1 ZNF462 PHF2 DST GPR158 SEC16A ANKRD28 TLN2 GCN1 DAGLA SIPA1L1 GIGYF2 TNKS1BP1 WDFY3 | 8.11e-09 | 225 | 342 | 15 | 12168954 | |
| Pubmed | 9.19e-09 | 4 | 342 | 4 | 18400243 | ||
| Pubmed | 9.78e-09 | 17 | 342 | 6 | 19968064 | ||
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 9.78e-09 | 17 | 342 | 6 | 20878400 | |
| Pubmed | 9.78e-09 | 17 | 342 | 6 | 20483367 | ||
| Pubmed | 9.78e-09 | 17 | 342 | 6 | 19450876 | ||
| Pubmed | 9.78e-09 | 17 | 342 | 6 | 19761533 | ||
| Pubmed | 9.78e-09 | 17 | 342 | 6 | 29911975 | ||
| Pubmed | 9.78e-09 | 17 | 342 | 6 | 20650299 | ||
| Pubmed | 9.78e-09 | 17 | 342 | 6 | 20173792 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 9.78e-09 | 17 | 342 | 6 | 19218127 | |
| Pubmed | 9.78e-09 | 17 | 342 | 6 | 19169284 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 1.09e-08 | 9 | 342 | 5 | 8662091 | |
| Pubmed | 1.09e-08 | 9 | 342 | 5 | 18340360 | ||
| Pubmed | ATXN2L CD2AP STK38 UNC45A THSD1 HNRNPA2B1 PTPN11 DST AHNAK SEC16A ALDH18A1 AFDN GCN1 VCL FLNB ANK3 DSP LARS1 EPB41L5 YTHDC2 SMC3 TRIM28 GIGYF2 TNKS1BP1 MARK2 RPL5 | 1.17e-08 | 708 | 342 | 26 | 39231216 | |
| Pubmed | TANC2 ATXN2L NAIP RUSC2 DST AJM1 RPTOR BSN MAP3K7 STXBP5L TNC SORBS1 GRIN2B SHANK2 SIPA1L1 GIGYF2 TNKS1BP1 MARK2 | 1.35e-08 | 347 | 342 | 18 | 17114649 | |
| Pubmed | 1.45e-08 | 18 | 342 | 6 | 20580654 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 1.45e-08 | 18 | 342 | 6 | 15570159 | |
| Pubmed | 1.45e-08 | 18 | 342 | 6 | 20519398 | ||
| Pubmed | 1.45e-08 | 18 | 342 | 6 | 19846535 | ||
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 1.45e-08 | 18 | 342 | 6 | 19630074 | |
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 1.45e-08 | 18 | 342 | 6 | 19046302 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 1.45e-08 | 18 | 342 | 6 | 10662547 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | UNC45A TUBA4A TUBA1B CLTC SEC16A ALDH18A1 GCN1 THRAP3 FLNA FLNB FLNC TUBA1C AHSA1 TRIM28 TNKS1BP1 | 1.45e-08 | 235 | 342 | 15 | 28378594 |
| Interaction | YWHAG interactions | KIAA0408 TANC2 CYLD ATXN2L TRAF3 RIPOR2 SPAST CD2AP CFTR DPYSL5 TUBA4A TUBA3C TESPA1 RUSC2 KANK1 DST PIK3C2B RPTOR PURA RECQL4 CLTC SEC16A AFDN CAMSAP2 NOS2 THRAP3 NOTCH2 VCL FAM110B USP53 FLNA CRTC3 UACA DSP TNIP2 EPB41L5 XIAP SORBS1 PRC1 IFI16 NCKAP5L CWC22 VIRMA CDC14A LRCH3 SAMD11 N4BP2 SIPA1L1 MARK4 GIGYF2 MARK2 ZMYM3 IL7R | 3.04e-10 | 1248 | 336 | 53 | int:YWHAG |
| Interaction | KCTD13 interactions | MTA2 TANC2 ATXN2L DDAH1 TRIO DPYSL5 TMOD2 HNRNPA2B1 JMY NLGN3 DST TUBA1A AJM1 RPTOR PURA CLTC SEC16A AFDN TLN2 BSN CORO7 CAMSAP2 DNAH6 NOS1 DAGLA THRAP3 MTUS2 GOLGA3 VCL SLC12A6 FLNA FLNB FLNC SRSF5 ANK3 DSP TNC TUBA1C LARS1 KIAA1549 YTHDC2 SORBS1 GRIN2B VIRMA LRCH3 ARPC2 SHANK2 TRIM28 SIPA1L1 LGI3 AP3B2 TNKS1BP1 MARK2 RPL5 | 5.30e-09 | 1394 | 336 | 54 | int:KCTD13 |
| Interaction | TCP11L2 interactions | 3.20e-08 | 21 | 336 | 7 | int:TCP11L2 | |
| Interaction | CAPZA2 interactions | CYLD ASXL1 CD2AP CFTR AASDHPPT UNC45A WASHC2A DST AHNAK RECQL4 CLTC SEC16A CRYBG1 AFDN GPNMB FLNA FLNB TNIP2 PRC1 VIRMA LRCH3 ARPC2 TRIM28 TNKS1BP1 MARK2 | 7.11e-08 | 430 | 336 | 25 | int:CAPZA2 |
| Interaction | APC interactions | SPAST CFTR NEB TUBA4A ASAP2 DST PLA2G4A ANKRD28 AFDN NOS2 FLNA RANBP9 LAMA3 SIRT6 PRC1 NCKAP5L VIRMA SYNE3 SMC3 CTNNA3 GIGYF2 MARK2 MBD5 | 1.78e-07 | 389 | 336 | 23 | int:APC |
| Interaction | YWHAH interactions | TANC2 CYLD ATXN2L SPAST TRIO CD2AP CFTR DPYSL5 PARD6G UNC45A TESPA1 RUSC2 KANK1 DST PIK3C2B RPTOR AHNAK PURA RECQL4 SEC16A AFDN PPIL2 MAP3K7 CAMSAP2 NOTCH2 VCL FAM110B USP53 CRTC3 UACA DSP EPB41L5 SORBS1 NCKAP5L CWC22 VIRMA CDC14A SAMD11 SIPA1L1 MARK4 GIGYF2 TNKS1BP1 MARK2 | 1.92e-07 | 1102 | 336 | 43 | int:YWHAH |
| Interaction | YWHAE interactions | MTA2 TANC2 CYLD ATXN2L CFTR TENT5C PARD6G TUBA3E HNRNPA2B1 TESPA1 RUSC2 KANK1 DST TUBA1A PIK3C2B RPTOR PURA RECQL4 CLTC AFDN MAP3K7 CAMSAP2 NOS2 GOLGA3 VCL FAM110B FLNA CRTC3 TNIP2 LARS1 SORBS1 PRC1 NCKAP5L VIRMA CDC14A LRCH3 MIDN TRIM28 SAMD11 SIPA1L1 STK33 MARK4 GIGYF2 MARK2 LCOR IL7R | 4.22e-07 | 1256 | 336 | 46 | int:YWHAE |
| Interaction | GLDC interactions | ATXN2L HNRNPA2B1 HNRNPH3 TUBA1B TUBA1A RECQL4 CLTC SEC16A TNRC6A THRAP3 FLNA FLNB UACA TUBA1C POLR2B NOP14 SMC3 SIPA1L1 GIGYF2 MARK2 | 5.06e-07 | 321 | 336 | 20 | int:GLDC |
| Interaction | CCT8 interactions | CYLD ASXL1 PADI4 SPAST ILK CFTR TUBA4A TUBA1B PTPN11 TUBA1A RPTOR RECQL4 ZBTB18 NOS2 FLNA FLNB FLNC TNIP2 TUBA1C LARS1 SIRT6 PRC1 IFI16 AHSA1 VIRMA TRIM28 TP63 | 6.26e-07 | 550 | 336 | 27 | int:CCT8 |
| Interaction | CAD interactions | CYLD ASXL1 ILK CFTR TUBA4A TUBA1A RPTOR RECQL4 CLTC SEC16A NOS2 TNIP2 TUBA1C LARS1 XIAP SIRT6 PPEF1 VIRMA SMC3 TRIM28 TP63 STK33 GIGYF2 | 6.31e-07 | 418 | 336 | 23 | int:CAD |
| Interaction | ENO1 interactions | CYLD ASXL1 NEXMIF CFTR TENT5C UNC45A NEB ITGAM TUBA4A HNRNPH3 PTPN11 KANK1 TUBA1A RPTOR AHNAK RECQL4 COL14A1 NOS2 FLNC FAT4 POLR1A ANK3 DUT RANBP9 IFI16 AHSA1 VIRMA NCOR1 SMC3 ENO3 TXLNG | 8.59e-07 | 701 | 336 | 31 | int:ENO1 |
| Interaction | LIMA1 interactions | MTA2 CFTR ADARB1 DST RPTOR AHNAK PURA CLTC SEC16A AFDN CAMSAP2 VCL FAM110B FLNA FLNB RANBP9 XIAP PRC1 VIRMA LRCH3 PIM3 SIPA1L1 GIGYF2 | 9.87e-07 | 429 | 336 | 23 | int:LIMA1 |
| Interaction | DTX4 interactions | 1.22e-06 | 22 | 336 | 6 | int:DTX4 | |
| Interaction | MYH9 interactions | MTA2 CYLD CFTR UNC45A ADARB1 TUBA4A DSN1 JMY TUBA1B DST RPTOR AHNAK CLTC SEC16A DNAH6 GOLGA3 VCL SEL1L FLNA FLNB SRSF5 UACA TRMO PRC1 VIRMA ARPC2 MIDN TP63 MARK4 GIGYF2 TNKS1BP1 HBZ | 1.38e-06 | 754 | 336 | 32 | int:MYH9 |
| Interaction | SH3PXD2A interactions | TANC2 ADAM19 RPTOR AHNAK PLA2G4A AFDN CAMSAP2 FAM110B VIRMA SIPA1L1 GIGYF2 MARK2 | 1.60e-06 | 128 | 336 | 12 | int:SH3PXD2A |
| Interaction | RBBP5 interactions | MTA2 FOXQ1 TUBA4A TUBA1A RECQL4 TNRC6A PPIL2 FLNA DCAF13 DSP BAZ2B POLR2B EPB41L5 TPRX2 SIRT6 VIRMA TRIM28 HLTF | 1.72e-06 | 287 | 336 | 18 | int:RBBP5 |
| Interaction | AKT1 interactions | CYLD CDKN2C ASXL1 PDE3A ILK CD2AP STOX1 NLGN3 PTPN11 KANK1 TUBA1A RPTOR AHNAK CLTC MTUS2 PMS2 SRSF5 DSP XIAP SORBS1 SIRT6 AHSA1 SHANK2 EIF4EBP1 MARK4 CHFR CARD11 MARK2 | 1.81e-06 | 617 | 336 | 28 | int:AKT1 |
| Interaction | CLTC interactions | CYLD ASXL1 CFTR WASHC2A HNRNPA2B1 EHBP1L1 ZFYVE9 PURA RECQL4 CLTC SEC16A TNRC6A MAP3K7 ZBTB18 VCL FKBP15 FLNA CRTC3 DSCAM TNIP2 LARS1 GRIN2B SIRT6 PRC1 VIRMA MIDN TRIM28 AP3B2 EDEM1 | 1.92e-06 | 655 | 336 | 29 | int:CLTC |
| Interaction | HNRNPC interactions | MTA2 CYLD TRAF3 RBMXL1 CFTR ITGAM ADARB1 F8 HNRNPA2B1 TUBA1B PTPN11 RECQL4 CAMSAP2 THRAP3 GOLGA3 SRSF5 DSP BAZ2B TNIP2 XIAP PRC1 CWC22 VIRMA MIDN NOP14 TRIM28 ENO3 IL7R | 3.05e-06 | 634 | 336 | 28 | int:HNRNPC |
| Interaction | PCBP1 interactions | MTA2 CYLD ATXN2L ASXL1 CD2AP CFTR ITGAM ADARB1 TUBA4A HNRNPA2B1 HNRNPH3 AHNAK RECQL4 CORO7 CAMSAP2 NOS2 HNRNPLL THRAP3 FLNA XIAP FBXO11 PRC1 VIRMA MIDN SMC3 TRIM28 GIGYF2 MBD5 RPL5 | 3.09e-06 | 671 | 336 | 29 | int:PCBP1 |
| Interaction | SEC16A interactions | TRAF3 ILK CFTR STK38 HNRNPA2B1 HNRNPH3 TUBA1A AHNAK RECQL4 CLTC SEC16A TNRC6A ANKRD28 VCL DSP TNIP2 SIRT6 PPEF1 VIRMA MKNK1 SYNE3 DDX20 | 3.13e-06 | 426 | 336 | 22 | int:SEC16A |
| Interaction | DCTN1 interactions | KIAA0408 MTA2 CYLD DCDC1 CFTR DST CLTC MIPEP SEC16A ANKRD28 CAMSAP2 ANKRD52 FLNC TNIP2 POLR2B RANBP9 YTHDC2 PRC1 NCKAP5L VIRMA TRIM28 MARK2 LCOR ENO3 | 3.55e-06 | 497 | 336 | 24 | int:DCTN1 |
| Interaction | PHLPP1 interactions | ATXN2L CD2AP STK38 UNC45A NEB TUBA4A TUBA1A AHNAK CLTC SEC16A PLA2G4A GCN1 FLNA FLNB DSP VIRMA GIGYF2 TNKS1BP1 MARK2 | 3.59e-06 | 333 | 336 | 19 | int:PHLPP1 |
| Interaction | GSK3B interactions | CYLD UBR1 ILK TRIO ACVRL1 WASHC2A HNRNPA2B1 TUBA1B PTPN11 DST TUBA1A RECQL4 CLTC SEC16A TNRC6A ANKRD28 MAP3K7 CAMSAP2 GOLGA3 NOTCH2 VCL FLNA ADAP1 XIAP YTHDC2 PRC1 SYNE3 TRIM28 SIPA1L1 EIF4EBP1 TNKS1BP1 DDX20 MARK2 EDEM1 | 3.73e-06 | 868 | 336 | 34 | int:GSK3B |
| Interaction | YWHAZ interactions | TANC2 CYLD ATXN2L ASXL1 RIPOR2 CFTR STK38 TENT5C PARD6G NEB TUBA3C TESPA1 RUSC2 KANK1 DST TUBA1A PIK3C2B RPTOR RECQL4 CLTC MLF1 ANKRD28 AFDN CAMSAP2 NOS1 NOS2 GOLGA3 VCL CRTC3 UACA SORBS1 IFI16 NCKAP5L VIRMA CDC14A SLC3A1 NCOR1 SIPA1L1 IGKC MARK4 CTNNA3 GIGYF2 WDFY3 MARK2 RPL5 | 3.82e-06 | 1319 | 336 | 45 | int:YWHAZ |
| Interaction | TAOK2 interactions | TANC2 PDE3A TUBA4A TUBA1A PURA ALDH18A1 AFDN MAP3K7 HNRNPLL DSP GRIN2B SYNE3 SHANK2 | 3.90e-06 | 164 | 336 | 13 | int:TAOK2 |
| Interaction | CIT interactions | MTA2 CYLD ATXN2L ILK RBMXL1 TMOD2 IRF5 ACVRL1 HNRNPA2B1 HNRNPH3 PHF2 UTP15 TUBA1A AHNAK CLTC ALDH18A1 TMEM97 GPNMB GCN1 HNRNPLL THRAP3 FLNA FLNB FLNC VRK2 DCAF13 DDX31 POLR1A SRSF5 DSCAM DSP POLR2B PCDHA6 YTHDC2 GRIN2B PRC1 IFI16 VIRMA TOE1 LIG3 NOP14 SMC3 TRIM28 HLTF CCDC120 TNKS1BP1 DDX20 RPL5 | 3.99e-06 | 1450 | 336 | 48 | int:CIT |
| Interaction | KCNA3 interactions | ATXN2L CD2AP STK38 UNC45A THSD1 HNRNPA2B1 PTPN11 ASAP2 DST RPTOR AHNAK SEC16A ALDH18A1 AFDN TLN2 BSN GCN1 VCL FLNB ANK3 DSP LARS1 EPB41L5 YTHDC2 SMC3 TRIM28 SIPA1L1 AP3B2 CTNNA3 GIGYF2 CARD11 TNKS1BP1 MARK2 RPL5 | 4.01e-06 | 871 | 336 | 34 | int:KCNA3 |
| Interaction | RICTOR interactions | ASXL1 ILK CD2AP STK38 UNC45A WASHC2A HNRNPA2B1 TUBA1B TUBA1A RPTOR AHNAK CLTC SEC16A AFDN TASOR GCN1 THRAP3 FLNA FLNB FLNC DSP LARS1 SIRT6 AHSA1 VIRMA NCOR1 TRIM28 EIF4EBP1 GIGYF2 TNKS1BP1 NCKAP1L | 4.44e-06 | 759 | 336 | 31 | int:RICTOR |
| Interaction | IQCB1 interactions | DDAH1 KRT74 TUBA4A HNRNPA2B1 TUBA1B PTPN11 TUBA1A RECQL4 SEC16A GCN1 FLNA FLNB FLNC DSP TUBA1C EPB41L5 SIRT6 TRIM28 SNAPC4 ENO3 | 4.49e-06 | 370 | 336 | 20 | int:IQCB1 |
| Interaction | GAPDH interactions | CYLD ASXL1 SPAST CFTR OBSCN UNC45A HNRNPA2B1 ASAP2 SAMD9L TUBA1A RECQL4 CLTC TLN2 FLNA SRSF5 DSP TNIP2 TUBA1C DUT SIRT6 PRC1 SPAG6 VIRMA WDR19 MIDN SMC3 TRIM28 ENO3 RPL5 | 4.74e-06 | 686 | 336 | 29 | int:GAPDH |
| Interaction | TESK2 interactions | USP9Y RPTOR AFDN CAMSAP2 GCN1 FAM110B POLR2B AHSA1 SIPA1L1 GIGYF2 | 5.06e-06 | 97 | 336 | 10 | int:TESK2 |
| Interaction | OTUD7A interactions | 5.10e-06 | 58 | 336 | 8 | int:OTUD7A | |
| Interaction | AMOT interactions | CYLD WASHC2A DAP3 SEC16A TNRC6A ANKRD28 CAMSAP2 ANKRD52 RAB3IL1 FKBP15 FLNA TNIP2 KIAA1549 SIRT6 MIDN N4BP2 SIPA1L1 CDH11 | 5.56e-06 | 312 | 336 | 18 | int:AMOT |
| Interaction | NUP43 interactions | MTA2 SPAST GON4L CSMD3 ZNF462 PHF2 DST TUBA1A RECQL4 ANKRD28 FLNA DDX31 DSCAM DSP BAZ2B SIRT6 PRC1 IFI16 CWC22 VIRMA NCOR1 LIG3 NOP14 HLTF LCOR RPL5 ZMYM3 | 6.90e-06 | 625 | 336 | 27 | int:NUP43 |
| Interaction | LATS2 interactions | MTA2 TANC2 CYLD CDKN2C SEC16A ALDH18A1 AFDN GCN1 NOTCH2 FBXW10 KIAA1549 SORBS1 NCKAP5L AHSA1 VIRMA SYNE3 SIPA1L1 | 7.85e-06 | 289 | 336 | 17 | int:LATS2 |
| Interaction | TRIM37 interactions | KIAA0408 TRAF3 KRT74 HNRNPA2B1 TUBA1B TUBA1A AHNAK CLTC SEC16A TNRC6A CAMSAP2 NOTCH2 FLNB DSCAM DSP XIAP PRC1 NCKAP5L VIRMA ARPC2 NCOR1 SYNE3 SIPA1L1 GIGYF2 CARD11 SNAPC4 RPL5 | 7.97e-06 | 630 | 336 | 27 | int:TRIM37 |
| Interaction | PATJ interactions | CD2AP TUBA1A AFDN FLNA HTR2A TNIP2 TUBA1C PCDHAC2 GRIN2B PRC1 VIRMA | 8.03e-06 | 125 | 336 | 11 | int:PATJ |
| Interaction | SIRT7 interactions | MTA2 ATXN2L DST UTP15 AHNAK CLTC SEC16A ALDH18A1 ANKRD28 AFDN GCN1 ANKRD52 VCL FLNA FLNB FLNC DCAF13 DDX31 POLR1A SRSF5 DSP TUBA1C YTHDC2 VIRMA NOP14 GIGYF2 TNKS1BP1 DDX20 RPL5 ZMYM3 | 8.18e-06 | 744 | 336 | 30 | int:SIRT7 |
| Interaction | ANXA2 interactions | CYLD ASXL1 CFTR HNRNPA2B1 PTPN11 ASB9 AHNAK RECQL4 PLA2G4A FLNA FBXW10 DSP TNC ZBTB4 RANBP9 SIRT6 PRC1 VIRMA SMC3 HLTF NCKAP1L | 8.32e-06 | 419 | 336 | 21 | int:ANXA2 |
| Interaction | CCT5 interactions | CYLD ASXL1 ILK CFTR TUBA4A TUBA1B PTPN11 TUBA1A RPTOR AHNAK RECQL4 ZBTB18 NOS2 DCAF13 TNIP2 TUBA1C SIRT6 PRC1 IFI16 VIRMA TRIM28 IGKC MBD5 LCOR | 8.95e-06 | 525 | 336 | 24 | int:CCT5 |
| Interaction | LRRC31 interactions | TRIO UNC45A TUBA1B TUBA1A AHNAK CLTC SEC16A CRYBG1 GCN1 FLNA FLNB UACA DSP BTAF1 | 9.42e-06 | 205 | 336 | 14 | int:LRRC31 |
| Interaction | ANKRD28 interactions | IRF5 RECQL4 SEC16A PLA2G4A ANKRD28 CAMSAP2 ANKRD52 NOTCH2 FLNC ANK3 UACA VIRMA LRCH3 TRMT2A SMC3 | 1.03e-05 | 235 | 336 | 15 | int:ANKRD28 |
| Interaction | MAGED1 interactions | CYLD SPAST ILK RUSC1 TUBA4A ARID5A RPTOR RECQL4 ANKRD28 MAP3K7 GCN1 HNRNPLL TNIP2 XIAP SMC3 TRIM28 CCDC120 | 1.03e-05 | 295 | 336 | 17 | int:MAGED1 |
| Interaction | RCOR1 interactions | MTA2 CD2AP UNC45A TUBA1B DST AHNAK RECQL4 SEC16A TASOR GCN1 ANKRD52 GOLGA3 FLNA DSP RANBP9 TPRX2 NCKAP5L VIRMA NCOR1 TRIM28 GIGYF2 TNKS1BP1 ZMYM3 | 1.03e-05 | 494 | 336 | 23 | int:RCOR1 |
| Interaction | EIF3F interactions | CYLD CFTR TUBA4A TUBA1B TUBA1A RECQL4 MYDGF FLNA HTR2A ANK3 PRC1 IFI16 VIRMA TRIM28 EIF4EBP1 CCDC120 LCOR | 1.07e-05 | 296 | 336 | 17 | int:EIF3F |
| Interaction | GRM7 interactions | 1.20e-05 | 19 | 336 | 5 | int:GRM7 | |
| Interaction | AP2M1 interactions | CYLD ATXN2L CFTR HNRNPA2B1 TUBA1B TUBA1A CLTC TNRC6A ANKRD28 CORO7 TASOR ANKRD52 FLNA TUBA1C GRIN2B AHSA1 CDC14A MIDN TRIM28 FURIN MARK2 | 1.23e-05 | 430 | 336 | 21 | int:AP2M1 |
| Interaction | HSP90AB1 interactions | CYLD ASXL1 ILK CFTR UNC45A NEB PTPN11 ASAP2 TUBA1A RPTOR AHNAK RECQL4 PLA2G4A MAP3K7 NOS2 FLNA ANK3 DSP BAZ2B TNIP2 TUBA1C LARS1 LAMA3 XIAP PRC1 AHSA1 VIRMA MKNK1 TNNI3K MIDN TP63 STK33 MARK2 MAPK13 RPL5 | 1.26e-05 | 960 | 336 | 35 | int:HSP90AB1 |
| Interaction | MYO6 interactions | CYLD ATXN2L CD2AP CFTR TMOD2 KANK1 ZFYVE9 RECQL4 CLTC SEC16A ANKRD28 FLNA LARS1 YTHDC2 VIRMA LRCH3 TRIM28 FURIN SIPA1L1 DDX20 | 1.32e-05 | 398 | 336 | 20 | int:MYO6 |
| Interaction | KSR1 interactions | TANC2 RPTOR PLA2G4A AFDN CAMSAP2 FAM110B CRTC3 VRK2 VIRMA SIPA1L1 GIGYF2 | 1.35e-05 | 132 | 336 | 11 | int:KSR1 |
| Interaction | SQSTM1 interactions | CYLD TRAF3 TRIO CHDH CFTR TENT5C HNRNPA2B1 TUBA1B DAP3 KANK1 TUBA1A PIK3C2B RPTOR AHNAK CLTC SEC16A TNRC6A CORO7 MAP3K7 FLNA FLNB DCAF13 TNC TUBA1C KHNYN POLR2B KERA XIAP YTHDC2 PRC1 IFI16 VIRMA TOE1 NCOR1 SYNE3 GIGYF2 TNKS1BP1 WDFY3 EDEM1 MAPK13 RPL5 IL7R | 1.37e-05 | 1257 | 336 | 42 | int:SQSTM1 |
| Interaction | CDH1 interactions | ATXN2L ILK CD2AP CFTR STK38 UNC45A EHBP1L1 DST PTPRD AHNAK CRYBG1 AFDN GCN1 GOLGA3 NOTCH2 VCL FLNA FLNB ANK3 UACA SORBS1 SIRT6 AHSA1 ARPC2 SHANK2 CTNNA3 GIGYF2 CCDC120 TNKS1BP1 MARK2 | 1.50e-05 | 768 | 336 | 30 | int:CDH1 |
| Interaction | B3GNT2 interactions | MON2 ATXN2L PDE3A B3GNT3 ITGA7 TUBA4A HNRNPA2B1 TUBA1B AHNAK PURA CLTC SEC16A GCN1 SEL1L TNC TNIP2 TUBA1C CHCHD6 IFI16 ARPC2 TRIM28 TNKS1BP1 DDX20 RPL5 | 1.51e-05 | 542 | 336 | 24 | int:B3GNT2 |
| Interaction | TUBB6 interactions | CYLD ILK CFTR ADARB1 TUBA4A TUBA1B TUBA1A RECQL4 NOS2 TNIP2 TUBA1C SIRT6 VIRMA TRIM28 FURIN | 1.53e-05 | 243 | 336 | 15 | int:TUBB6 |
| Interaction | KIF20A interactions | RBMXL1 DPYSL5 TMOD2 USP9Y HNRNPA2B1 HNRNPH3 ZNF462 SAMD9L AHNAK CLTC SEC16A TNRC6A GPNMB GCN1 THRAP3 SEL1L FLNA FLNB FLNC SRSF5 UACA DSP TNIP2 CHCHD6 SIRT6 PRC1 IFI16 VIRMA CDC14A LGALS4 LRCH3 ARPC2 FER1L4 HLTF GIGYF2 SNAPC4 RPL5 | 1.55e-05 | 1052 | 336 | 37 | int:KIF20A |
| Interaction | PRMT1 interactions | CYLD ATXN2L TRAF3 STK38 HNRNPA2B1 HNRNPH3 TUBA1B TUBA1A PURA RECQL4 CLTC SEC16A ALDH18A1 MAP3K7 TASOR THRAP3 GOLGA3 FLNA FLNB FLNC DSP TNIP2 LARS1 RANBP9 YTHDC2 IFI16 VIRMA SMC3 TRIM28 N4BP2 GIGYF2 DDX20 WDFY3 RPL5 | 1.56e-05 | 929 | 336 | 34 | int:PRMT1 |
| Interaction | KIR2DS3 interactions | 1.58e-05 | 20 | 336 | 5 | int:KIR2DS3 | |
| Interaction | CCAR2 interactions | CYLD FOXQ1 CFTR TENT5C ADARB1 NLGN3 TUBA1A PURA RECQL4 CLTC SEC16A TNRC6A HNRNPLL SIRT6 PPEF1 IFI16 VIRMA TRIM28 | 1.59e-05 | 337 | 336 | 18 | int:CCAR2 |
| Interaction | SSR4 interactions | CYLD ASXL1 ILK CFTR NLGN3 RECQL4 NOS2 TUBA1C PRC1 PPEF1 VIRMA MIDN TP63 RPL5 | 1.70e-05 | 216 | 336 | 14 | int:SSR4 |
| Interaction | TANC2 interactions | 1.76e-05 | 89 | 336 | 9 | int:TANC2 | |
| Interaction | CDC42 interactions | TANC2 UBR1 PDE3A TRAF3 ILK TRIO CFTR PARD6G ZDHHC8 SDR39U1 TUBA1B PTPN2 EHBP1L1 TUBA1A AHNAK RECQL4 CLTC ALDH18A1 AFDN CORO7 THRAP3 NOTCH2 FLNA FLNC FAT4 VRK2 ANK3 DSP TUBA1C DUT LARS1 EPB41L5 KIAA1549 XIAP GRIN2B IFI16 NCKAP5L LRCH3 ARPC2 TRIM28 MARK4 MARK2 ZNF415 | 2.09e-05 | 1323 | 336 | 43 | int:CDC42 |
| Interaction | PSMC4 interactions | CYLD ASXL1 SPAST CFTR TENT5C TUBA4A TUBA1B PTPN2 RPTOR RECQL4 NOS2 FLNC TNIP2 IFI16 AHSA1 VIRMA MIDN TRIM28 | 2.09e-05 | 344 | 336 | 18 | int:PSMC4 |
| Interaction | LRP1 interactions | TUBA4A F8 BDNF PTPN11 TUBA1A NGF TUBA1C RANBP9 GRIN2B VIRMA FURIN CHFR LCOR | 2.67e-05 | 196 | 336 | 13 | int:LRP1 |
| Interaction | KIF13B interactions | TANC2 RPTOR AFDN CAMSAP2 FAM110B CRTC3 VIRMA TRIM28 SIPA1L1 GIGYF2 MARK2 | 2.68e-05 | 142 | 336 | 11 | int:KIF13B |
| Interaction | CCDC6 interactions | CYLD CD2AP PIK3C2B RPTOR SEC16A TNRC6A ANKRD52 MTUS2 FLNA TNIP2 SORBS1 SIRT6 VIRMA TRIM28 N4BP2 TNKS1BP1 | 2.69e-05 | 286 | 336 | 16 | int:CCDC6 |
| Interaction | PHLDB2 interactions | CFTR AFDN CAMSAP2 FAM110B FLNA FLNC ANK3 VIRMA ARPC2 SIPA1L1 GIGYF2 | 2.87e-05 | 143 | 336 | 11 | int:PHLDB2 |
| Interaction | G3BP1 interactions | MTA2 CYLD ATXN2L TENT5C AASDHPPT TUBA4A TUBA3C PTPN2 DST PURA RECQL4 ALDH18A1 CRYBG1 GCN1 FLNA FLNB DSP TUBA1C POLR2B SORBS1 SIRT6 PRC1 IFI16 CWC22 VIRMA TMEM232 SIPA1L1 GIGYF2 TNKS1BP1 RPL5 IL7R | 2.88e-05 | 835 | 336 | 31 | int:G3BP1 |
| Interaction | PPP6R3 interactions | MTA2 CFTR IRF5 WASHC2A TUBA1B RECQL4 MLF1 ANKRD28 ANKRD52 THRAP3 GOLGA3 EPB41L5 SIRT6 VIRMA TRMT2A | 3.07e-05 | 258 | 336 | 15 | int:PPP6R3 |
| Interaction | TNIP1 interactions | MTA2 ATXN2L TRAF3 RBMXL1 CACNA2D2 UNC45A HNRNPA2B1 TUBA1B DST UTP15 AHNAK CLTC MLF1 PPIL2 THRAP3 FLNA FLNB DCAF13 POLR1A UACA DSP TNIP2 POLR2B LARS1 EPB41L5 PRC1 IFI16 TOE1 LRCH3 ARPC2 LIG3 SYNE3 TRMT2A SMC3 TRIM28 IGKC CARD11 DDX20 MARK2 RPL5 | 3.24e-05 | 1217 | 336 | 40 | int:TNIP1 |
| Interaction | PCDHA8 interactions | 3.43e-05 | 55 | 336 | 7 | int:PCDHA8 | |
| Interaction | EEF1G interactions | MTA2 CYLD ASXL1 TRAF3 CFTR HNRNPH3 TUBA1B RECQL4 ANKRD28 THRAP3 FLNC TNIP2 LARS1 SIRT6 PRC1 VIRMA NOP14 TRIM28 CHFR HLTF RPL5 | 3.67e-05 | 463 | 336 | 21 | int:EEF1G |
| Interaction | RBBP4 interactions | MTA2 CYLD ASXL1 CFTR DSN1 ZNF462 TUBA1A RPTOR RECQL4 THRAP3 GOLGA3 FLNA DSP TUBA1C SIRT6 PRC1 IFI16 VIRMA NCOR1 MIDN SMC3 TRIM28 LCOR ZMYM3 | 3.70e-05 | 573 | 336 | 24 | int:RBBP4 |
| Interaction | GSK3A interactions | CYLD TRIO ACVRL1 WASHC2A KANK1 DST SEC16A TNRC6A CRYBG1 ANKRD28 CAMSAP2 THRAP3 GOLGA3 VCL YTHDC2 TRIM28 SIPA1L1 TNKS1BP1 MARK2 LCOR RPL5 | 3.78e-05 | 464 | 336 | 21 | int:GSK3A |
| Interaction | HDAC6 interactions | CYLD RIPOR2 CFTR UNC45A TUBA4A HNRNPA2B1 TUBA1B PTPN11 UTP15 TUBA1A AHNAK RECQL4 CLTC SEC16A AFDN MAP3K7 FKBP15 FLNA FLNB UACA DSP TUBA1C RANBP9 FBXO11 AHSA1 VIRMA LRCH3 ARPC2 LIG3 TRIM28 LCOR RPL5 ZMYM3 | 3.78e-05 | 929 | 336 | 33 | int:HDAC6 |
| Interaction | SLC25A13 interactions | CYLD ASXL1 ILK CFTR TUBA1A RECQL4 ANK3 LARS1 PRC1 PPEF1 IFI16 VIRMA MIDN TRIM28 FURIN | 3.83e-05 | 263 | 336 | 15 | int:SLC25A13 |
| Interaction | CCT7 interactions | CYLD ASXL1 ILK TUBA3E ITGAM TUBA4A TUBA1B PTPN11 TUBA1A RPTOR RECQL4 ZBTB18 NOS2 FLNC GALNT10 DCAF13 BAZ2B TNIP2 TUBA1C SIRT6 VIRMA TRIM28 DDX20 MBD5 | 3.91e-05 | 575 | 336 | 24 | int:CCT7 |
| Interaction | PLEC interactions | CYLD ATXN2L CFTR ADARB1 DST AHNAK RECQL4 MLF1 NOS2 THRAP3 USP53 FLNA ANK3 DSCAM PRC1 VIRMA MIDN SYNE3 SMC3 N4BP2 | 3.96e-05 | 430 | 336 | 20 | int:PLEC |
| Interaction | ZNF765 interactions | 4.10e-05 | 24 | 336 | 5 | int:ZNF765 | |
| Interaction | TRIM66 interactions | MON2 CYLD RPTOR SEC16A TNRC6A ANKRD28 NOTCH2 FAT3 YTHDC2 TRMT2A SIPA1L1 MARK4 WDFY3 | 4.26e-05 | 205 | 336 | 13 | int:TRIM66 |
| Interaction | TEDC2 interactions | TRIO TUBA1B ASAP2 DST TUBA1A AHNAK CLTC AFDN GCN1 DSP CWC22 SLC3A1 TRIM28 | 4.48e-05 | 206 | 336 | 13 | int:TEDC2 |
| Interaction | CDC5L interactions | TANC2 CYLD TRIO UNC45A TUBA4A HNRNPA2B1 TUBA1B DST AHNAK RECQL4 TLN2 PPIL2 GCN1 HNRNPLL MTUS2 SRSF5 USB1 DSP TUBA1C BTAF1 PRC1 IFI16 CWC22 VIRMA CDC14A MIDN NOP14 SMC3 HLTF TNKS1BP1 MARK2 | 4.49e-05 | 855 | 336 | 31 | int:CDC5L |
| Interaction | ACE2 interactions | MTA2 UBR1 ATXN2L TRPM4 KRT74 TUBA3E TUBA4A HNRNPA2B1 HNRNPH3 TUBA1B ZFYVE9 PTPRD TUBA1A CLTC ALDH18A1 PPIL2 GCN1 THRAP3 GOLGA3 NOTCH2 USP53 FLNA FLNB CRTC3 DCAF13 SRSF5 DSP TUBA1C LARS1 LIG3 NOP14 SHANK2 TRIM28 GIGYF2 CCDC120 DDX20 RPL5 | 4.53e-05 | 1106 | 336 | 37 | int:ACE2 |
| Interaction | LGALS1 interactions | CYLD CFTR ITGA7 NLGN3 NEO1 PTPRD NOTCH2 VCL SLC12A6 FLNA FAT4 DCAF13 FAT3 RANBP9 KIAA1549 MUC16 PRC1 | 4.64e-05 | 332 | 336 | 17 | int:LGALS1 |
| Interaction | KIR2DL2 interactions | 4.82e-05 | 13 | 336 | 4 | int:KIR2DL2 | |
| Interaction | KDM1A interactions | KIAA0408 MTA2 CD2AP RUSC1 UNC45A ADARB1 ZNF462 DST AHNAK RECQL4 SEC16A TNRC6A ANKRD28 TASOR ZBTB18 GCN1 ANKRD52 GOLGA3 FLNA FLNB DSP POLR2B RANBP9 C8orf74 TPRX2 SIRT6 VIRMA NCOR1 TRIM28 N4BP2 GIGYF2 TNKS1BP1 ZMYM3 | 4.86e-05 | 941 | 336 | 33 | int:KDM1A |
| Interaction | PPP1CC interactions | TANC2 TRAF3 RBMXL1 HNRNPA2B1 DSN1 SDR39U1 HNRNPH3 RUSC2 ZFYVE9 RECQL4 CLTC CAMSAP2 THRAP3 FLNA SRSF5 UACA TNIP2 POLR2B RANBP9 GRIN2B PRC1 VIRMA NCOR1 MIDN TRIM28 ZNF667 C9orf50 RPL5 | 4.87e-05 | 738 | 336 | 28 | int:PPP1CC |
| Interaction | INSL5 interactions | 4.88e-05 | 58 | 336 | 7 | int:INSL5 | |
| Interaction | ACLY interactions | CYLD ASXL1 TRAF3 CFTR HNRNPA2B1 PTPN11 RECQL4 SEC16A FLNC DSP TNIP2 SIRT6 IFI16 AHSA1 VIRMA PIM3 TRIM28 | 5.19e-05 | 335 | 336 | 17 | int:ACLY |
| Interaction | MECP2 interactions | MTA2 ATXN2L RBMXL1 DPYSL5 STK38 USP9Y HNRNPA2B1 HNRNPH3 ZNF462 PHF2 DAP3 EHBP1L1 DST TUBA1A PURA CLTC PPIL2 GCN1 HNRNPLL THRAP3 FKBP15 FLNC DCAF13 DDX31 SRSF5 DSP POLR2B FBXO11 PCDHA1 PRC1 CWC22 TOE1 NCOR1 LIG3 NOP14 SMC3 TRIM28 TNKS1BP1 TNXB RPL5 ZMYM3 | 5.19e-05 | 1287 | 336 | 41 | int:MECP2 |
| Interaction | KRT8 interactions | CYLD DCDC1 KRT74 CFTR SEC16A TNRC6A CRYBG1 ANKRD28 CAMSAP2 ANKRD52 NOS2 GOLGA3 SEL1L USP53 UACA DSP TNIP2 VIRMA N4BP2 SIPA1L1 | 5.62e-05 | 441 | 336 | 20 | int:KRT8 |
| Interaction | TOP3B interactions | MON2 MTA2 TANC2 TRPM4 GTPBP6 TRIO OBSCN DGKQ IRF5 UNC45A WASHC2A ZDHHC8 EHBP1L1 DST PIK3C2B RPTOR AHNAK SEC16A TLN2 GCN1 NOTCH2 FLNA FLNC KHNYN ZBTB4 LARS1 AKNA BTAF1 CDC14A ARPC2 PIM3 NCOR1 LIG3 SYNE3 SHANK2 TRIM28 FURIN MARK4 TNKS1BP1 DDX20 WDFY3 MAPKBP1 SNAPC4 MBD5 TXLNG | 5.64e-05 | 1470 | 336 | 45 | int:TOP3B |
| Interaction | YWHAQ interactions | TANC2 CYLD ATXN2L PDE3A CFTR DPYSL5 NEB HNRNPA2B1 TUBA3C RUSC2 KANK1 DST TUBA1A PIK3C2B RPTOR RECQL4 CLTC AFDN CAMSAP2 GCN1 NOS2 VCL FLNA CRTC3 UACA TUBA1C EPB41L5 SORBS1 SIRT6 IFI16 NCKAP5L VIRMA CDC14A TRIM28 SAMD11 SIPA1L1 MARK2 | 5.67e-05 | 1118 | 336 | 37 | int:YWHAQ |
| Interaction | CCT2 interactions | CYLD ASXL1 ILK CFTR TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A RPTOR RECQL4 ZBTB18 NOS2 VRK2 DCAF13 DSP TNIP2 TUBA1C CRPPA XIAP PRC1 AHSA1 VIRMA TRIM28 DDX20 LCOR | 5.71e-05 | 666 | 336 | 26 | int:CCT2 |
| Interaction | AP2B1 interactions | KIAA0408 CYLD CFTR TENT5C HNRNPA2B1 RECQL4 CLTC SEC16A TNRC6A ANKRD28 FKBP15 FLNA DSCAM LARS1 VIRMA MIDN N4BP2 FURIN | 6.01e-05 | 373 | 336 | 18 | int:AP2B1 |
| Interaction | MCM2 interactions | RBMXL1 CFTR TUBA3E NEB TUBA4A HNRNPA2B1 TUBA3C DST TUBA1A AHNAK RECQL4 CLTC SEC16A C4B MAP3K7 GCN1 FKBP15 FLNA FLNB FLNC CRTC3 ANK3 DSP TNIP2 TUBA1C DUT MUC16 SIRT6 AHSA1 VIRMA SMC3 TRIM28 CHFR GIGYF2 TNKS1BP1 RPL5 | 6.33e-05 | 1081 | 336 | 36 | int:MCM2 |
| Interaction | H1-10 interactions | CYLD CFTR HNRNPA2B1 RECQL4 DNAH6 SRSF5 ANK3 POLR2B RANBP9 PRC1 IFI16 MIDN MBD5 RPL5 IL7R | 7.80e-05 | 280 | 336 | 15 | int:H1-10 |
| Interaction | PINK1 interactions | MTA2 ATXN2L TRAF3 HNRNPA2B1 TUBA1B DST TUBA1A AHNAK CLTC C4B MAP3K7 GCN1 THRAP3 VCL FLNA FLNB FLNC DSP TUBA1C LARS1 PM20D1 SMC3 TRIM28 IGKC MARK2 RPL5 | 7.83e-05 | 679 | 336 | 26 | int:PINK1 |
| Interaction | RPA4 interactions | ATXN2L RIPOR2 CD2AP AASDHPPT UNC45A WASHC2A HNRNPA2B1 DST UTP15 AHNAK SEC16A AFDN MAP3K7 THRAP3 FLNA PRC1 NCOR1 LIG3 TRIM28 RPL5 | 7.88e-05 | 452 | 336 | 20 | int:RPA4 |
| Interaction | FOXO1 interactions | TRAF3 CD2AP WASHC2A HNRNPA2B1 GPR179 HNRNPH3 AHNAK C4B GOLGA3 VCL DSP TUBA1C VIRMA IGKC GIGYF2 LCOR ENO3 | 7.99e-05 | 347 | 336 | 17 | int:FOXO1 |
| Cytoband | 19q13.4 | KIR2DS2 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1 SIGLEC12 ZNF17 TRIM28 | 8.28e-09 | 79 | 342 | 9 | 19q13.4 |
| Cytoband | 5q31 | 2.64e-05 | 115 | 342 | 7 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | KRT74 ACVRL1 ITGA7 TESPA1 TUBA1B TUBA1A ANKRD52 TUBA1C NCKAP5L IKZF4 C12orf54 NCKAP1L | 9.25e-05 | 423 | 342 | 12 | chr12q13 |
| Cytoband | 12q13.12 | 1.83e-04 | 38 | 342 | 4 | 12q13.12 | |
| Cytoband | 10q22.2 | 2.47e-04 | 41 | 342 | 4 | 10q22.2 | |
| GeneFamily | Tubulins | 2.41e-08 | 26 | 227 | 7 | 778 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 6.00e-08 | 18 | 227 | 6 | 620 | |
| GeneFamily | Ankyrin repeat domain containing | TANC2 CDKN2C AGAP5 ILK AGAP11 ASAP2 KANK1 ASB9 ANKRD28 ANKRD52 NOTCH2 ANK3 UACA SHANK2 ANKRD60 AGAP9 | 7.30e-08 | 242 | 227 | 16 | 403 |
| GeneFamily | Fibronectin type III domain containing | 3.52e-05 | 160 | 227 | 10 | 555 | |
| GeneFamily | Cadherin related | 5.07e-05 | 17 | 227 | 4 | 24 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 5.07e-05 | 17 | 227 | 4 | 1291 | |
| GeneFamily | ArfGAPs | 5.32e-05 | 33 | 227 | 5 | 395 | |
| GeneFamily | Clustered protocadherins | 1.50e-04 | 64 | 227 | 6 | 20 | |
| GeneFamily | WD repeat domain containing | FBXW10B UTP15 RPTOR CORO7 ATG16L2 FBXW10 DCAF13 STXBP5L WDR19 WDFY3 MAPKBP1 | 4.94e-04 | 262 | 227 | 11 | 362 |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 7.95e-04 | 15 | 227 | 3 | 26 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 9.89e-04 | 161 | 227 | 8 | 593 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 1.39e-03 | 18 | 227 | 3 | 1160 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.08e-03 | 181 | 227 | 8 | 694 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 2.28e-03 | 6 | 227 | 2 | 699 | |
| GeneFamily | PDZ domain containing | 3.12e-03 | 152 | 227 | 7 | 1220 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 3.16e-03 | 7 | 227 | 2 | 785 | |
| GeneFamily | G protein-coupled receptors, Class C orphans | 3.16e-03 | 7 | 227 | 2 | 285 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 4.18e-03 | 8 | 227 | 2 | 419 | |
| GeneFamily | EF-hand domain containing|Plakins | 4.18e-03 | 8 | 227 | 2 | 939 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.38e-03 | 53 | 227 | 4 | 532 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 5.33e-03 | 9 | 227 | 2 | 1234 | |
| GeneFamily | Hemoglobin subunits | 6.61e-03 | 10 | 227 | 2 | 940 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 6.61e-03 | 10 | 227 | 2 | 830 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 CYLD RIPOR2 SPAST TMOD2 RUSC1 NEB CSMD3 BDNF RUSC2 ZNF462 FAT2 GPR158 TNRC6A PCDH11X TLN2 FGF9 BSN CAMSAP2 MTUS2 GOLGA3 FKBP15 ADAP1 ANK3 DSCAM CCDC186 LAMA3 KIAA1549 SORBS1 IKZF4 SHANK2 RASA4 SAMD11 N4BP2 AP3B2 RGS17 | 3.80e-07 | 1106 | 338 | 36 | M39071 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CYLD UBR1 ATXN2L RIPOR2 ADAM19 ADARB1 TUBA4A HNRNPA2B1 JMY TESPA1 ARID5A HNRNPH3 PTPN2 PTPN11 SAMD9L TUBA1A AHNAK CRYBG1 ANKRD28 TASOR HNRNPLL THRAP3 NOTCH2 FLNA SRSF5 POLR2B ZBTB4 RANBP9 AKNA XIAP FBXO11 YTHDC2 BTAF1 IFI16 CDC14A ARPC2 NCOR1 SMC3 CARD11 EDEM1 RPL5 IL7R NCKAP1L | 7.11e-07 | 1492 | 338 | 43 | M40023 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | PDE3A CD2AP GON4L ZNF462 NLGN3 PTPN11 PTPRD AHNAK CLTC TNRC6A MYDGF TASOR PCDH18 THRAP3 FLNC FAT4 BAZ2B NCOR1 FURIN GIGYF2 TNKS1BP1 | 8.74e-07 | 467 | 338 | 21 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | PDE3A CD2AP GON4L ZNF462 NLGN3 PTPN11 PTPRD AHNAK CLTC TNRC6A MYDGF TASOR PCDH18 THRAP3 FLNC FAT4 BAZ2B NCOR1 FURIN GIGYF2 TNKS1BP1 | 1.54e-06 | 484 | 338 | 21 | MM999 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | TRIO CD2AP TUBA4A DST NOTCH2 VCL FLNA FLNB RANBP9 PRC1 SMC3 MARK4 | 1.16e-05 | 199 | 338 | 12 | M5893 |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | CYLD RIPOR2 ACVRL1 ITGA7 ADARB1 TESPA1 ARID5A DST COL14A1 SORBS1 IFI16 SYNE3 RASA4 TP63 IGKC SIGLEC1 TNXA IL7R NCKAP1L | 2.04e-05 | 485 | 338 | 19 | M8513 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | TRAF3 DDAH1 TUBA3E TUBA3C PTPN11 CLTC TMEM97 GCN1 NOTCH2 DSP POLR2B DUT SMC3 | 2.45e-05 | 250 | 338 | 13 | M11318 |
| Coexpression | PEDRIOLI_MIR31_TARGETS_DN | N4BP2L1 PADI4 EXD3 NEO1 FAT2 KANK1 SAMD9L PLA2G4A AFDN CORO7 PCDHA13 CDC14A ZNF667 HLTF CARD11 ZNF415 ENO3 | 3.00e-05 | 413 | 338 | 17 | M2494 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | CDKN2C FOXQ1 SPAST GTPBP6 TENT5C PARD6G AASDHPPT B3GNT3 TUBA4A EHBP1L1 AHNAK SEC16A TMEM97 NANOS1 PCDH18 GOLGA3 VCL SEL1L SLC12A6 GALNT10 RANBP9 XIAP N4BP2 ABHD13 MAPK13 CDH11 | 4.37e-05 | 845 | 338 | 26 | M18090 |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | ADAM19 CD2AP ADARB1 HNRNPA2B1 PHF2 DAP3 PTPN11 PIK3C2B PURA PCDH11X PLA2G4A CRYBG1 ANKRD28 TASOR ZBTB18 NOS1 SRSF5 POLR2B IFI16 IGKC HLTF EDEM1 NCKAP1L | 5.05e-05 | 705 | 338 | 23 | M1410 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ASXL1 SPAST TRIO CD2AP ADARB1 BDNF HNRNPH3 PTPN2 ASAP2 DST ZFYVE9 ANKRD28 CAMSAP2 TASOR ZBTB18 VCL FLNB BAZ2B POLR2B BTAF1 SMC3 SIPA1L1 HLTF GIGYF2 WDFY3 IL7R | 5.41e-05 | 856 | 338 | 26 | M4500 |
| Coexpression | GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP | ADAM19 STK38 DSN1 PHKA2 LMF2 VCL TUBA1C DERA NCOR1 WDFY3 NCKAP1L | 5.67e-05 | 198 | 338 | 11 | M5344 |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN | FBXO10 TNRC6A POLR1A AKNA LAMA3 CHCHD6 TRMT2A N4BP2 SIPA1L1 HLTF RPL5 | 6.21e-05 | 200 | 338 | 11 | M6185 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | PDE3A FOXQ1 TRIO PARD6G TUBA3E JMY BDNF DST PCDH11X TLN2 MAP3K7 CAMSAP2 GCN1 PCDH18 VCL FAM110B SEL1L FAT4 ANK3 DSP TNC FAT3 LAMA3 XIAP HIF3A IFI16 IKZF4 LIG3 TP63 SIPA1L1 GIGYF2 HBZ CDH11 | 4.09e-07 | 806 | 329 | 33 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_100 | 1.71e-05 | 11 | 329 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | PDE3A FOXQ1 PARD6G JMY BDNF DST PCDH11X CAMSAP2 FAT4 ANK3 DSP TNC FAT3 XIAP IFI16 TP63 SIPA1L1 GIGYF2 HBZ | 2.20e-05 | 407 | 329 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_200 | 2.89e-05 | 24 | 329 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | FOXQ1 GPR87 BDNF ZNF462 NLGN3 NEO1 FAT2 ASAP2 DST UTP15 ALDH18A1 COL14A1 DSP TNC IFI16 NCOR1 SMC3 TP63 GIGYF2 | 4.35e-05 | 428 | 329 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.70e-05 | 108 | 329 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | PDE3A TRAF3 FOXQ1 TRIO TMOD2 PARD6G BDNF NLGN3 DST PTPRD PCDH11X TLN2 MAP3K7 CAMSAP2 GCN1 PCDH18 FAT4 ANK3 DSP TNC FAT3 LAMA3 XIAP HIF3A IFI16 LIG3 TP63 GIGYF2 | 6.32e-05 | 806 | 329 | 28 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | FOXQ1 CFTR TENT5C PARD6G GPR87 BDNF ZNF462 DST CRYBG1 FGF9 CAMSAP2 PCDH18 SEL1L FAT4 DSP LAMA3 KIAA1549 XIAP HIF3A IFI16 TP63 HLTF GIGYF2 RGS17 GALNT5 HBZ CDH11 | 7.17e-05 | 769 | 329 | 27 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TANC2 FOXQ1 GPR87 AASDHPPT NEB BDNF HNRNPH3 ZNF462 NLGN3 NEO1 DST UTP15 ALDH18A1 COL14A1 PCDH18 DDX31 DSP TNC FAT3 XIAP IFI16 NCOR1 MIDN SMC3 TP63 GIGYF2 ABHD13 LCOR | 1.17e-04 | 836 | 329 | 28 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_500 | 1.24e-04 | 96 | 329 | 8 | gudmap_developingLowerUrinaryTract_P1_ureter_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 1.44e-04 | 33 | 329 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | TANC2 DDAH1 FOXQ1 GPR87 AASDHPPT NEB BDNF HNRNPH3 ZNF462 NLGN3 NEO1 FAT2 ASAP2 DST UTP15 ALDH18A1 COL14A1 PCDH18 DDX31 DSP TNC KHNYN IFI16 NCOR1 MIDN SMC3 TP63 GIGYF2 | 1.55e-04 | 850 | 329 | 28 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_1000 | FOXQ1 CD2AP GPR87 SAMD9L DST AHNAK CRYBG1 DSP LAMA3 PM20D1 FER1L4 TP63 | 1.61e-04 | 218 | 329 | 12 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | CDKN2C PDE3A TRPC3 CD2AP TMOD2 JMY NEO1 EHBP1L1 DST PURA PCDH11X COL14A1 CAMSAP2 VCL SEL1L FAT4 CCDC186 ZBTB4 KIAA1549 XIAP SORBS1 ADAMTS8 GIGYF2 RGS17 EDEM1 CDH11 | 1.89e-04 | 772 | 329 | 26 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_500 | 2.20e-04 | 36 | 329 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | PDE3A FOXQ1 TRIO PARD6G DST PCDH11X TLN2 GCN1 PCDH18 FAT4 ANK3 TNC FAT3 XIAP IFI16 TP63 GIGYF2 | 2.32e-04 | 408 | 329 | 17 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | KIAA0408 ZNF462 FNDC1 GPR158 PCDH11X PCDH18 FLNA ANK3 BAZ2B TNC CRPPA CTNNA3 TNXB CDH11 | 4.51e-10 | 200 | 337 | 14 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 CFTR OBSCN NEB CSMD3 PTPRD PCDH11X TLN2 FAT4 STXBP5L FAT3 GRIN2B GUCY2F | 1.70e-09 | 184 | 337 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 CFTR OBSCN NEB CSMD3 PTPRD PCDH11X TLN2 FAT4 STXBP5L FAT3 GRIN2B GUCY2F | 1.70e-09 | 184 | 337 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 CFTR OBSCN NEB CSMD3 PTPRD PCDH11X TLN2 FAT4 STXBP5L FAT3 GRIN2B GUCY2F | 1.70e-09 | 184 | 337 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | DCDC1 PLEKHS1 STOX1 DNAH6 ERICH3 DSP MUC16 SPAG6 SHANK2 TMEM232 STK33 | 2.24e-08 | 151 | 337 | 11 | 8216462e723fec2797387929dde095370947e10a |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | PDE3A ADARB1 DST COL14A1 TLN2 USP53 UACA FAT3 ADAMTS8 HIF3A TNXB CDH11 | 3.57e-08 | 196 | 337 | 12 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | ADARB1 DST PTPRD USP53 FAT4 UACA TNC FAT3 ADAMTS8 HIF3A TNXB CDH11 | 4.46e-08 | 200 | 337 | 12 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | ADARB1 DST PTPRD USP53 FAT4 UACA TNC FAT3 ADAMTS8 HIF3A TNXB CDH11 | 4.46e-08 | 200 | 337 | 12 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | PTPN2 NEO1 PTPRD TUBA1A FGF9 ZBTB18 ANK3 FAT3 GRIN2B ARPC2 RGS17 RPL5 | 4.46e-08 | 200 | 337 | 12 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | PTPN2 NEO1 PTPRD TUBA1A FGF9 ZBTB18 ANK3 FAT3 GRIN2B ARPC2 RGS17 RPL5 | 4.46e-08 | 200 | 337 | 12 | c831d9e0a7178e3634da45548f91fa9e8dc6557c |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ADARB1 DST PTPRD USP53 FAT4 UACA TNC FAT3 ADAMTS8 HIF3A TNXB CDH11 | 4.46e-08 | 200 | 337 | 12 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | TPO PDE3A F8 CC2D2B KCNH6 PIK3C2B NOS1 FAT4 UACA GRIN2B IHO1 | 6.71e-08 | 168 | 337 | 11 | aca34c51758c65925ad24110294a72b2dea6db72 |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | PDE3A ITGA7 ADARB1 COL14A1 TLN2 MTUS2 FLNA FAT3 MAGEC3 SORBS1 CDH11 | 1.35e-07 | 180 | 337 | 11 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | PDE3A DDAH1 ADARB1 COL14A1 VCL FLNA FLNB TNC FAT3 LAMA3 SORBS1 | 2.10e-07 | 188 | 337 | 11 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DDAH1 CD2AP SAMD9L TASOR THRAP3 DSP BAZ2B CCDC186 XIAP NCOR1 LCOR | 2.46e-07 | 191 | 337 | 11 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | CPAMD8 DDAH1 CFTR KANK1 AFDN ANK3 DSCAM EPB41L5 LAMA3 SHANK2 CTNNA3 | 2.46e-07 | 191 | 337 | 11 | d3733c8c4bda70c4390e5601fdda6188a64be944 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DDAH1 CD2AP SAMD9L TASOR THRAP3 DSP BAZ2B CCDC186 XIAP NCOR1 LCOR | 2.46e-07 | 191 | 337 | 11 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | CYLD UBR1 ASXL1 TRAF3 ARID5A MLF1 COL14A1 VCL USP53 FBXO11 SORBS1 | 2.60e-07 | 192 | 337 | 11 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | TENT5C STOX1 ZBTB18 NOS2 STXBP5L MUC16 PCDHA6 RASA4 ZNF667 TNXB | 2.88e-07 | 154 | 337 | 10 | 212c340a096a3a9669d1aebd61c045cf1402a868 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | PDE3A ADARB1 DST COL14A1 FAT4 UACA TNC FAT3 SNED1 TNXB CDH11 | 3.71e-07 | 199 | 337 | 11 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | RIPOR2 CACNA2D2 STK38 ITGAM AHNAK KIR2DL3 KIR3DL1 VCL FLNA RPL5 IL7R | 3.71e-07 | 199 | 337 | 11 | 00ef3cc5c02639bfb839075ecf5f20026ff81f84 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | CPAMD8 CACNA2D2 CFTR OBSCN THSD1 AHNAK DDX31 WDR19 NOP14 MBD5 TXLNG | 3.90e-07 | 200 | 337 | 11 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.90e-07 | 200 | 337 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDE3A ADAM19 ITGA7 FNDC1 COL14A1 FLNA FLNC TNC FAT3 SORBS1 CTNNA3 | 3.90e-07 | 200 | 337 | 11 | a66449b22b39dd6987fc2c3ed160d24564234ced |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.90e-07 | 200 | 337 | 11 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDE3A ADARB1 DST COL14A1 USP53 UACA FAT3 ADAMTS8 HIF3A TNXB CDH11 | 3.90e-07 | 200 | 337 | 11 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | KIAA0408 PDE3A TRPC3 FNDC1 PCDH11X PCDH18 VCL FLNA TUBA1C ADAMTS8 CTNNA3 | 3.90e-07 | 200 | 337 | 11 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | CAPN9 GPR87 PLEKHS1 B3GNT3 FAT2 PLA2G4A DSP MUC16 TP63 GALNT5 | 8.86e-07 | 174 | 337 | 10 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 179 | 337 | 10 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.33e-06 | 182 | 337 | 10 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | CAPN9 CACNA2D2 BDNF FNDC1 FLNB DSP EPB41L5 LAMA3 TNNI3K GALNT5 | 1.40e-06 | 183 | 337 | 10 | 6821dca076318115d360ff426eb1218cfe104063 |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-06 | 187 | 337 | 10 | 173f029dcf32af008f517912f6d110a33a9e98cf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | ADAM19 TUBA4A JMY CORO7 HNRNPLL AHSA1 CDC14A FURIN TXLNG IL7R | 1.87e-06 | 189 | 337 | 10 | 284f39dfacec76004daae9dd5317fb7b1f04fa99 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CPAMD8 DDAH1 CFTR KANK1 ANK3 EPB41L5 LAMA3 HIF3A SHANK2 CTNNA3 | 1.97e-06 | 190 | 337 | 10 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.97e-06 | 190 | 337 | 10 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | RIPOR2 ADAM19 TENT5C TUBA4A TESPA1 CRYBG1 ANK3 CDC14A CARD11 IL7R | 1.97e-06 | 190 | 337 | 10 | d57df208aaf7a5554899bb9107c80b443fd0cf93 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-06 | 191 | 337 | 10 | 2a107e9096eb58b81b3da61547904d85754f6b2f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-06 | 191 | 337 | 10 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.06e-06 | 191 | 337 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | KIAA0408 PDE3A FNDC1 COL14A1 NOTCH2 TNC FAT3 CRPPA SNED1 TNXB | 2.06e-06 | 191 | 337 | 10 | 14057205ddb9b4bbc582d1358d13cf36d979a61b |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-06 | 191 | 337 | 10 | d35692c652977500a3c36aa26c347a072b71e441 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-06 | 191 | 337 | 10 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | RIPOR2 ADAM19 TENT5C TUBA4A TESPA1 CRYBG1 ANK3 CDC14A CARD11 IL7R | 2.16e-06 | 192 | 337 | 10 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA2D2 OBSCN TUBA4A MLF1 MTUS2 ERICH3 DSP TNNI3K CTNNA3 ENO3 | 2.16e-06 | 192 | 337 | 10 | f6a4e348406a852ace9fb21db8fbdff539217645 |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA2D2 OBSCN TUBA4A MLF1 MTUS2 ERICH3 DSP TNNI3K CTNNA3 ENO3 | 2.16e-06 | 192 | 337 | 10 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.26e-06 | 193 | 337 | 10 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.26e-06 | 193 | 337 | 10 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | RIPOR2 ADAM19 TENT5C TUBA4A JMY TESPA1 CRYBG1 ANKRD28 CDC14A IL7R | 2.26e-06 | 193 | 337 | 10 | 9c9434a3297b85774b4f0ecab6294f44d738e29f |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | TENT5C ITGAD TUBA4A JMY CRYBG1 KIR2DL3 KIR3DL1 SRSF5 AKNA MIDN | 2.48e-06 | 195 | 337 | 10 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | FOXQ1 KRT74 CFTR EXD3 PLA2G4A NOTCH2 ATG16L2 DSP LAMA3 ITPRID1 | 2.48e-06 | 195 | 337 | 10 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 195 | 337 | 10 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.48e-06 | 195 | 337 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Trm_Th1/Th17|Liver / Manually curated celltypes from each tissue | ADAM19 TENT5C PARD6G TUBA4A AHNAK CRYBG1 ANKRD28 HNRNPLL PIM3 IL7R | 2.48e-06 | 195 | 337 | 10 | 480cc62ee1e5b1aaf6b62be6e5afd7a81236a1b0 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 195 | 337 | 10 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | DPYSL5 TMOD2 PARD6G TLN2 GPNMB VCL KIAA1549 PCDHAC2 PCDHA2 RASA4 | 2.48e-06 | 195 | 337 | 10 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.48e-06 | 195 | 337 | 10 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.72e-06 | 197 | 337 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.72e-06 | 197 | 337 | 10 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 2.72e-06 | 197 | 337 | 10 | 8545baf923ddf84c5ce9414a36d810603be52401 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDE3A ADAM19 VSX1 ITGA7 ADARB1 FLNA FLNC SORBS1 ADAMTS8 HIF3A | 2.72e-06 | 197 | 337 | 10 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | SAMD9L AHNAK SEC16A KIR3DL1 FLNA GALNT10 ZBTB4 AKNA CARD11 TNKS1BP1 | 2.85e-06 | 198 | 337 | 10 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CPAMD8 STK38 PLEKHS1 B3GNT3 PTPRD FLNB ANK3 DSP SHANK2 RGS17 | 2.85e-06 | 198 | 337 | 10 | af399569c718f5fd971d73a7926768c9311002a3 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | TANC2 TRIO KANK1 PTPRD ANK3 EPB41L5 SHANK2 SIPA1L1 WDFY3 MBD5 | 2.85e-06 | 198 | 337 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.85e-06 | 198 | 337 | 10 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.98e-06 | 199 | 337 | 10 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | RIPOR2 CACNA2D2 STK38 TUBA4A KIR2DL3 KIR3DL1 VCL FLNA RPL5 IL7R | 2.98e-06 | 199 | 337 | 10 | 0902b08e3386e64d7347c186d9ce5b67f2deaabb |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CPAMD8 PDE3A ADARB1 PTPRD PCDH11X COL14A1 FAT4 TNC SNED1 CDH11 | 3.11e-06 | 200 | 337 | 10 | a4ec0e80f5422b91b85264a9bb74568dd577e285 |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.11e-06 | 200 | 337 | 10 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.11e-06 | 200 | 337 | 10 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 3.11e-06 | 200 | 337 | 10 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-06 | 200 | 337 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 3.11e-06 | 200 | 337 | 10 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.11e-06 | 200 | 337 | 10 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | CPAMD8 CACNA2D2 CFTR OBSCN THSD1 AHNAK MIDN NOP14 ENO3 TXLNG | 3.11e-06 | 200 | 337 | 10 | be83f442179ba4217d12f0458059586ff3130991 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.11e-06 | 200 | 337 | 10 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | KIAA0408 NLGN3 FNDC1 GPR158 PCDH11X PCDH18 FAT4 TNC TNXB CDH11 | 3.11e-06 | 200 | 337 | 10 | a799fc7bb83ad0524362cb5010df949741fb7bf3 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.11e-06 | 200 | 337 | 10 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | KIAA0408 CPAMD8 DST PTPRD COL14A1 PCDH18 TNC ADAMTS8 TNXB CDH11 | 3.11e-06 | 200 | 337 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 164 | 337 | 9 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.04e-06 | 166 | 337 | 9 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.04e-06 | 166 | 337 | 9 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 5.29e-06 | 167 | 337 | 9 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.41e-06 | 171 | 337 | 9 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-06 | 172 | 337 | 9 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-06 | 172 | 337 | 9 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.04e-06 | 173 | 337 | 9 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-06 | 175 | 337 | 9 | 9a96794df049d8228fea57c1584c160191d36b56 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.09e-06 | 176 | 337 | 9 | fc5787946f5a10056d326d070620575ae4081836 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.09e-06 | 176 | 337 | 9 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.09e-06 | 176 | 337 | 9 | d30241fb8119834d6e7b59efec3f92fc7a3d1247 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.09e-06 | 176 | 337 | 9 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|ILC / Donor, Lineage, Cell class and subclass (all cells) | 8.19e-06 | 37 | 337 | 5 | 5208860d6b87c6c6fbf6e6c262fb2efc712ec2d3 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.47e-06 | 177 | 337 | 9 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.47e-06 | 177 | 337 | 9 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.86e-06 | 178 | 337 | 9 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.86e-06 | 178 | 337 | 9 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.86e-06 | 178 | 337 | 9 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 179 | 337 | 9 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 9.27e-06 | 179 | 337 | 9 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 179 | 337 | 9 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| Drug | Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A | CAPN9 CYLD ATXN2L TRPM4 TENT5C GON4L GPR87 EHBP1L1 LMF2 DSCAM CCDC186 FBXO11 YTHDC2 LIG3 SIPA1L1 | 3.17e-07 | 199 | 338 | 15 | 7348_UP |
| Drug | Epothilone D | 5.09e-07 | 12 | 338 | 5 | DB01873 | |
| Drug | Epothilone B | 5.09e-07 | 12 | 338 | 5 | DB03010 | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | CYLD ATXN2L TRPM4 TRAF3 EHBP1L1 PPIL2 DSCAM KHNYN YTHDC2 LIG3 TRMT2A MARK4 MAPKBP1 EDEM1 | 1.59e-06 | 197 | 338 | 14 | 2814_DN |
| Drug | 7-NI | 2.33e-06 | 78 | 338 | 9 | CID000001893 | |
| Drug | LY83583 | NOS1 NANOS1 NOS2 SLC12A6 SLC3A1 GUCY2F CARD11 MAPK13 HBQ1 HBZ | 3.77e-06 | 105 | 338 | 10 | CID000003976 |
| Drug | NOC-7 | 6.86e-06 | 19 | 338 | 5 | CID000001383 | |
| Drug | rofecoxib | 7.31e-06 | 113 | 338 | 10 | ctd:C116926 | |
| Drug | CP-645525-01 [287190-82-3]; Down 200; 10uM; MCF7; HT_HG-U133A | TRIO IRF5 B3GNT3 PHKA2 EXD3 FAM110B SRSF5 TNC SIRT6 CDC14A MARK4 SNAPC4 TXLNG | 8.42e-06 | 197 | 338 | 13 | 7522_DN |
| Drug | Bethanechol chloride [590-63-6]; Up 200; 20.4uM; MCF7; HT_HG-U133A | MTA2 ATXN2L NEB ARID5A SLC12A6 FKBP15 IFI16 CDC14A SLC3A1 IKZF4 LGALS4 SIPA1L1 ZNF415 | 8.90e-06 | 198 | 338 | 13 | 3537_UP |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | CAPN9 MTA2 ASXL1 THSD1 NEB ZKSCAN5 PPIL2 TMEM97 RAB3IL1 SLC12A6 EPB41L5 LIG3 WDFY3 | 8.90e-06 | 198 | 338 | 13 | 842_UP |
| Drug | diaspirin | 9.70e-06 | 34 | 338 | 6 | CID000065042 | |
| Drug | S-nitrosocysteine | 1.01e-05 | 93 | 338 | 9 | CID003359494 | |
| Drug | discodermolide | 1.16e-05 | 35 | 338 | 6 | CID000643668 | |
| Drug | SIN-1 chloride | 1.28e-05 | 53 | 338 | 7 | CID000065388 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1.28e-05 | 4 | 338 | 3 | DB07574 | |
| Drug | guanidinoglutaric acid | 1.45e-05 | 11 | 338 | 4 | CID000002105 | |
| Drug | trans-3,4,5-trihydroxystilbene | RIPOR2 TUBA3E TUBA4A PTPN2 PTPN11 TUBA1A PIK3C2B MYDGF NOS1 NANOS1 NOS2 TUBA1C DUT XIAP GRIN2B SIRT6 CDC14A NCOR1 GUCY2F CARD11 MAPK13 HBQ1 HBZ ENO3 | 1.52e-05 | 608 | 338 | 24 | CID000005056 |
| Drug | baccatin III | 1.61e-05 | 37 | 338 | 6 | CID000065366 | |
| Drug | L-Citrulline | 2.15e-05 | 12 | 338 | 4 | DB00155 | |
| Drug | Demecolcine | CDKN2C ASXL1 TRIO TENT5C GON4L ITGAM TUBA4A TUBA3C SAMD9L TUBA1A AHNAK ANKRD28 GPNMB MAP3K7 ERICH3 TUBA3D TUBA1C EPB41L5 YTHDC2 SORBS1 IFI16 LRCH3 FUT11 SMC3 C12orf54 GIGYF2 MBD5 LCOR IL7R RSKR | 2.16e-05 | 878 | 338 | 30 | ctd:D003703 |
| Drug | Methamphetamine | ATXN2L RIPOR2 DDAH1 DPYSL5 OBSCN GON4L PARD6G THSD1 ACVRL1 BDNF TUBA1B EHBP1L1 LMF2 DST AHNAK TNRC6A NGF GPNMB MAP3K7 NOS1 NOS2 FKBP15 FLNA FLNB FLNC HTR2A DSP DUT SORBS1 BTAF1 GRIN2B SIRT6 TOE1 THPO STPG1 SMC3 RASA4 LGI3 EIF4EBP1 GIGYF2 RGS17 | 2.63e-05 | 1401 | 338 | 41 | ctd:D008694 |
| Drug | S-nitroso-N-acetyl-D,L-penicillamine | 3.26e-05 | 134 | 338 | 10 | CID000005231 | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | CAPN9 TANC2 TRIO NEB KCNH6 TLN2 PPIL2 ANK3 GUCY2F MAPK13 CDH11 NCKAP1L | 3.37e-05 | 193 | 338 | 12 | 2482_UP |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | MTA2 TANC2 N4BP2L1 RIPOR2 TRIO PTPRD AHNAK PPIL2 EPB41L5 HIF3A TP63 CTNNA3 | 3.73e-05 | 195 | 338 | 12 | 4298_UP |
| Drug | Vincristine | CYLD CDKN2C ASXL1 TRIO TENT5C GON4L ITGAM TUBA4A HNRNPA2B1 TUBA3C TUBA1B EHBP1L1 PTPN11 RECQL4 NGF GPNMB MAP3K7 NOS1 CRTC3 ERICH3 HTR2A TUBA3D CCDC186 TNIP2 TUBA1C YTHDC2 PRC1 LRCH3 FUT11 C12orf54 IGKC RGS17 MAPKBP1 LCOR RPL5 RSKR | 3.74e-05 | 1182 | 338 | 36 | ctd:D014750 |
| Drug | Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; HL60; HT_HG-U133A | IRF5 UNC45A NEB ADARB1 PHKA2 EXD3 KANK1 AHNAK PPIL2 RAB3IL1 LIG3 ZNF667 | 3.92e-05 | 196 | 338 | 12 | 1276_UP |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | CAPN9 MTA2 TENT5C ITGA7 GPNMB ZBTB18 DSCAM USB1 SLC3A1 THPO TP63 WDFY3 | 3.92e-05 | 196 | 338 | 12 | 4785_UP |
| Drug | naftidrofuryl | 3.93e-05 | 43 | 338 | 6 | CID000004417 | |
| Drug | Zaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A | CDKN2C ATXN2L GPR87 ZKSCAN5 EHBP1L1 ZFYVE9 PPIL2 DAGLA LAMA3 CDC14A ZNF34 SIPA1L1 | 4.12e-05 | 197 | 338 | 12 | 5349_UP |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | TRIO TRPC3 TESPA1 ARID5A PTPRD AHNAK AFDN SEL1L STXBP5L SPAG6 WDFY3 CDH11 | 4.12e-05 | 197 | 338 | 12 | 4181_UP |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | MON2 TRPM4 IRF5 ZKSCAN5 PHKA2 YTHDC2 NCOR1 LIG3 SHANK2 TRMT2A MARK2 SNAPC4 | 4.12e-05 | 197 | 338 | 12 | 6773_DN |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | TRPM4 CACNA2D2 GON4L THSD1 ADARB1 PPIL2 NOTCH2 SEL1L DDX31 TRMO FBXO11 CDC14A | 4.12e-05 | 197 | 338 | 12 | 4222_DN |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; HL60; HT_HG-U133A | PHKA2 EHBP1L1 ZFYVE9 AHNAK NOS1 NOTCH2 USB1 WDR19 SNED1 MARK4 MAPK13 ENO3 | 4.12e-05 | 197 | 338 | 12 | 2350_UP |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; MCF7; HT_HG-U133A | ATXN2L TRIO CACNA2D2 EHBP1L1 ASB9 TLN2 NOTCH2 SLC12A6 STXBP5L SIRT6 CDC14A LIG3 | 4.12e-05 | 197 | 338 | 12 | 7486_DN |
| Drug | LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A | ATXN2L ZKSCAN5 ARID5A EXD3 LMF2 MLF1 CAMSAP2 NOTCH2 FLNB FBXO11 WDFY3 MAPK13 | 4.12e-05 | 197 | 338 | 12 | 6175_DN |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HT_HG-U133A | PECR BDNF PLA2G4A DDX31 TNC TRMO FBXO11 CDC14A SLC3A1 ZNF34 RGS17 TXLNG | 4.12e-05 | 197 | 338 | 12 | 4216_DN |
| Drug | GEA 3162 | 4.25e-05 | 14 | 338 | 4 | CID003035443 | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; PC3; HT_HG-U133A | ATXN2L DGKQ ITGA7 COL14A1 TLN2 NOTCH2 DSCAM TRMO FBXO11 YTHDC2 LGALS4 LIG3 | 4.33e-05 | 198 | 338 | 12 | 4601_UP |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; HL60; HT_HG-U133A | MTA2 CYLD TRIO IRF5 ZFYVE9 TLN2 DCAF13 SRSF5 ANK3 STXBP5L HIF3A THPO | 4.33e-05 | 198 | 338 | 12 | 2554_UP |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A | CACNA2D2 GON4L B3GNT3 LMF2 PPIL2 RAB3IL1 SLC12A6 DSCAM LGALS4 SHANK2 TRMT2A MARK4 | 4.54e-05 | 199 | 338 | 12 | 6810_DN |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | CAPN9 CYLD N4BP2L1 EHBP1L1 PPIL2 DAGLA VCL FAT4 EPB41L5 SORBS1 TP63 SIGLEC1 | 4.54e-05 | 199 | 338 | 12 | 5094_UP |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | ATXN2L BDNF ZFYVE9 COL14A1 PPIL2 USP53 STXBP5L TNC CDC14A LIG3 TP63 MARK2 | 4.54e-05 | 199 | 338 | 12 | 3058_DN |
| Drug | B-Ms | 5.20e-05 | 114 | 338 | 9 | CID000445091 | |
| Drug | l956 | 5.72e-05 | 15 | 338 | 4 | CID000017814 | |
| Drug | S-nitrosoacetylcysteine | 6.20e-05 | 29 | 338 | 5 | CID000122058 | |
| Drug | bp U | 6.20e-05 | 29 | 338 | 5 | CID000368697 | |
| Drug | N-nitroso-L-arginine | 6.27e-05 | 6 | 338 | 3 | CID000127762 | |
| Drug | NapNa | 6.27e-05 | 6 | 338 | 3 | CID000128726 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | PDE3A DDAH1 CACNA2D2 CFTR PHKA2 PIK3C2B NOS1 NANOS1 NOS2 SLC12A6 SIRT6 GUCY2F CARD11 HBQ1 HBZ | 6.32e-05 | 308 | 338 | 15 | CID000001915 |
| Drug | colchine | CFTR TUBA3E TUBA4A BDNF DST TUBA1A NGF COL14A1 FGF9 BSN NOS1 NANOS1 NOS2 VCL TNC TUBA1C LAMA3 | 6.61e-05 | 383 | 338 | 17 | CID000002833 |
| Drug | DiC8 | 6.77e-05 | 146 | 338 | 10 | CID000001323 | |
| Drug | papaverine | PDE3A CACNA2D2 CFTR DST NOS1 NANOS1 NOS2 GUCY2F CARD11 HBQ1 HBZ | 6.81e-05 | 176 | 338 | 11 | CID000004680 |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | CYLD TENT5C TMOD2 THSD1 TUBA4A LMF2 MLF1 ZBTB18 SLC12A6 SORBS1 WDR19 | 6.81e-05 | 176 | 338 | 11 | 5441_UP |
| Drug | 1xa5 | 7.39e-05 | 93 | 338 | 8 | CID000157684 | |
| Drug | GaCl3 | 9.38e-05 | 50 | 338 | 6 | CID000026010 | |
| Drug | DNTB | PADI4 TRH ITGAM KIR2DL3 KIR2DS1 KIR2DS3 POLR2B SPAG6 SMC3 SIGLEC1 HBQ1 HBZ | 9.98e-05 | 216 | 338 | 12 | CID000015325 |
| Drug | 2-demethylcolchicine | 1.01e-04 | 32 | 338 | 5 | CID000023757 | |
| Drug | AC1NLRUC | 1.09e-04 | 7 | 338 | 3 | CID004988604 | |
| Drug | chloroquine | PADI4 IRF5 ITGAM CLTC COL14A1 KIR2DS1 KIR2DS3 NOS1 NANOS1 NOS2 SIGLEC1 MAPK13 HBQ1 HBZ | 1.13e-04 | 288 | 338 | 14 | CID000002719 |
| Drug | zinc protoporphyrin | 1.13e-04 | 126 | 338 | 9 | CID000027287 | |
| Drug | 1,3-dipropylxanthine | 1.15e-04 | 74 | 338 | 7 | CID000169317 | |
| Drug | mebendazole | 1.18e-04 | 33 | 338 | 5 | CID000004030 | |
| Drug | 2,3-diaminonaphthalene | 1.24e-04 | 18 | 338 | 4 | CID000069872 | |
| Drug | manganese | CACNA2D2 TUBA3E ITGA7 ITGAD ITGAM TUBA4A TUBA1B PHKA2 FAT2 ZFYVE9 TUBA1A NOS1 NANOS1 NOS2 GALNT10 POLR1A TUBA1C POLR2B LAMA3 LIG3 SMC3 GUCY2F CARD11 HBQ1 HBZ ENO3 | 1.44e-04 | 791 | 338 | 26 | CID000023930 |
| Drug | trifluralin | 1.52e-04 | 131 | 338 | 9 | CID000005569 | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A | PLEKHS1 B3GNT3 HNRNPH3 NOTCH2 PMS2 ANK3 CCDC186 EPB41L5 YTHDC2 CDC14A SLC3A1 | 1.55e-04 | 193 | 338 | 11 | 4725_UP |
| Drug | MPTP-HCl | 1.61e-04 | 162 | 338 | 10 | CID000001388 | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | CYLD CFTR DGKQ NOS1 VCL EPB41L5 SORBS1 IKZF4 THPO SHANK2 SIGLEC1 | 1.62e-04 | 194 | 338 | 11 | 2504_UP |
| Drug | Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; HL60; HT_HG-U133A | DDAH1 ADAM19 TRPC3 TENT5C ARID5A PTPN2 NOS1 DSCAM MAGEC3 FBXO11 TP63 | 1.62e-04 | 194 | 338 | 11 | 2391_UP |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | TENT5C TESPA1 AFDN RAB3IL1 DAGLA VCL YTHDC2 CDC14A ZNF34 SHANK2 MARK4 | 1.62e-04 | 194 | 338 | 11 | 3245_UP |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | TENT5C B3GNT3 ZKSCAN5 RUSC2 PHKA2 DAGLA FLNC USB1 KHNYN MARK4 MAPKBP1 | 1.62e-04 | 194 | 338 | 11 | 3539_DN |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A | MTA2 CYLD ADARB1 LMF2 PPIL2 RAB3IL1 SLC12A6 YTHDC2 TP63 SIPA1L1 WDFY3 | 1.69e-04 | 195 | 338 | 11 | 5240_UP |
| Drug | Bethanechol chloride [590-63-6]; Up 200; 20.4uM; HL60; HT_HG-U133A | CYLD ATXN2L EXD3 KANK1 AHNAK AFDN PPIL2 CAMSAP2 GALNT10 CDC14A ENO3 | 1.69e-04 | 195 | 338 | 11 | 2975_UP |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; HL60; HG-U133A | N4BP2L1 TRAF3 UNC45A DSN1 PTPN11 PPIL2 MAP3K7 TRMO FBXO11 SIRT6 IFI16 | 1.69e-04 | 195 | 338 | 11 | 1366_DN |
| Drug | Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | TRPM4 ADAM19 IRF5 ITGAM EHBP1L1 TLN2 PPIL2 RAB3IL1 USB1 SPAG6 SIPA1L1 | 1.69e-04 | 195 | 338 | 11 | 7406_UP |
| Drug | AC1Q4P61 | 1.72e-04 | 8 | 338 | 3 | CID000125039 | |
| Drug | Milrinone | 1.72e-04 | 8 | 338 | 3 | ctd:D020105 | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HT_HG-U133A | MTA2 TRH ITGA7 RUSC2 AHNAK PPIL2 GPNMB RAB3IL1 NOTCH2 YTHDC2 IFI16 | 1.77e-04 | 196 | 338 | 11 | 4591_UP |
| Drug | Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | CYLD CDKN2C B3GNT3 ZKSCAN5 LMF2 ANKRD28 PPIL2 USB1 EPB41L5 NCOR1 SHANK2 | 1.77e-04 | 196 | 338 | 11 | 6844_DN |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | CYLD TRH CACNA2D2 B3GNT3 USP9Y KCNH6 EXD3 EHBP1L1 RAB3IL1 SRSF5 STXBP5L | 1.77e-04 | 196 | 338 | 11 | 2784_UP |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | PLEKHS1 NEB ARID5A PPIL2 PMS2 STXBP5L CCDC186 MAGEC3 FBXO11 PCDHA6 CDC14A | 1.77e-04 | 196 | 338 | 11 | 4720_UP |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | THSD1 RUSC2 PPIL2 FAT4 SRSF5 ANK3 TNC TRMO YTHDC2 ZNF34 SNAPC4 | 1.77e-04 | 196 | 338 | 11 | 5081_DN |
| Drug | AC1L8WWP | 1.78e-04 | 56 | 338 | 6 | CID000388944 | |
| Drug | indazole | 1.78e-04 | 56 | 338 | 6 | CID000009221 | |
| Drug | 3-bromo-7-nitroindazole | 1.81e-04 | 36 | 338 | 5 | CID000001649 | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | CYLD N4BP2L1 CACNA2D2 GPR87 PLEKHS1 THSD1 KCNH6 COL14A1 LIG3 TP63 MAPK13 | 1.85e-04 | 197 | 338 | 11 | 5495_UP |
| Drug | Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | MTA2 CYLD N4BP2L1 IRF5 PPIL2 CAMSAP2 RAB3IL1 HIF3A LIG3 MARK2 ZMYM3 | 1.85e-04 | 197 | 338 | 11 | 2379_DN |
| Drug | Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; HL60; HT_HG-U133A | N4BP2L1 NEB EHBP1L1 ZFYVE9 MLF1 SEL1L USB1 STXBP5L SIPA1L1 WDFY3 MAPK13 | 1.85e-04 | 197 | 338 | 11 | 2412_DN |
| Drug | Hexestrol [84-16-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | CDKN2C TRPM4 IRF5 NEB ZKSCAN5 EHBP1L1 ZFYVE9 PPIL2 TMEM97 CDC14A MAPK13 | 1.85e-04 | 197 | 338 | 11 | 6077_DN |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | TRAF3 CACNA2D2 EHBP1L1 LMF2 PPIL2 DSCAM USB1 CCDC186 FBXO11 LIG3 MARK2 | 1.85e-04 | 197 | 338 | 11 | 7344_UP |
| Drug | Benperidol [2062-84-2]; Up 200; 10.4uM; HL60; HT_HG-U133A | TRPC3 ADARB1 PTPN2 ZFYVE9 ASB9 MLF1 FGF9 FLNC CDC14A LIG3 CDH11 | 1.85e-04 | 197 | 338 | 11 | 2475_UP |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | TRIO PTPN2 EHBP1L1 LMF2 TLN2 PPIL2 RAB3IL1 ANK3 LAMA3 NCOR1 FURIN | 1.85e-04 | 197 | 338 | 11 | 1473_DN |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | CYLD ATXN2L TRIO TENT5C THSD1 TLN2 SEL1L DDX31 SRSF5 FBXO11 LGALS4 | 1.85e-04 | 197 | 338 | 11 | 5274_DN |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | MON2 CACNA2D2 ARID5A FAT2 PPIL2 HTR2A SORBS1 CDC14A SLC3A1 AP3B2 MARK2 | 1.85e-04 | 197 | 338 | 11 | 3364_UP |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; PC3; HT_HG-U133A | CYLD UNC45A F8 TESPA1 PHKA2 TLN2 DAGLA SEL1L CDC14A SLC3A1 WDFY3 | 1.85e-04 | 197 | 338 | 11 | 6686_DN |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | MON2 N4BP2L1 RIPOR2 ITGA7 RUSC2 LMF2 PPIL2 USB1 THPO TP63 MARK4 | 1.93e-04 | 198 | 338 | 11 | 6494_UP |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A | THSD1 ZKSCAN5 LMF2 SEL1L DCAF13 CDC14A LRCH3 NCOR1 SIPA1L1 MARK4 WDFY3 | 1.93e-04 | 198 | 338 | 11 | 2297_DN |
| Drug | Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | ADARB1 PLA2G4A NOTCH2 DDX31 TRMO SORBS1 CDC14A ZNF34 LIG3 RGS17 TXLNG | 1.93e-04 | 198 | 338 | 11 | 4258_DN |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | B3GNT3 THSD1 EHBP1L1 LMF2 KHNYN PCDHA6 YTHDC2 NCOR1 LIG3 TRMT2A WDFY3 | 1.93e-04 | 198 | 338 | 11 | 3603_DN |
| Disease | microlissencephaly (implicated_via_orthology) | 1.46e-13 | 8 | 325 | 7 | DOID:0112234 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 1.46e-13 | 8 | 325 | 7 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 1.46e-13 | 8 | 325 | 7 | DOID:0112232 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 8.41e-12 | 27 | 325 | 9 | DOID:0050453 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | TANC2 SPAST TRIO NEXMIF PHF2 PTPN11 PURA DSCAM GRIN2B SMC3 GIGYF2 WDFY3 | 4.89e-10 | 93 | 325 | 12 | C1535926 |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.32e-06 | 3 | 325 | 3 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.32e-06 | 3 | 325 | 3 | DOID:0111190 (implicated_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 1.50e-05 | 29 | 325 | 5 | EFO_0008009 | |
| Disease | Epilepsy | 2.88e-05 | 109 | 325 | 8 | C0014544 | |
| Disease | post-traumatic stress disorder symptom measurement | 3.46e-05 | 82 | 325 | 7 | EFO_0008535 | |
| Disease | visceral adipose tissue measurement, body mass index | 5.07e-05 | 87 | 325 | 7 | EFO_0004340, EFO_0004765 | |
| Disease | asymmetrical dimethylarginine measurement | 7.12e-05 | 8 | 325 | 3 | EFO_0006522 | |
| Disease | epilepsy (implicated_via_orthology) | 8.66e-05 | 163 | 325 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | bacterial meningitis (biomarker_via_orthology) | 1.21e-04 | 2 | 325 | 2 | DOID:9470 (biomarker_via_orthology) | |
| Disease | Frontometaphyseal dysplasia | 1.21e-04 | 2 | 325 | 2 | C0265293 | |
| Disease | FRONTOMETAPHYSEAL DYSPLASIA 1 | 1.21e-04 | 2 | 325 | 2 | C4281559 | |
| Disease | Frontometaphyseal dysplasia | 1.21e-04 | 2 | 325 | 2 | cv:C0265293 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.50e-04 | 10 | 325 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.01e-04 | 49 | 325 | 5 | DOID:0060037 (implicated_via_orthology) | |
| Disease | nucleus accumbens volume change measurement | 2.05e-04 | 11 | 325 | 3 | EFO_0021493 | |
| Disease | neuroticism measurement, cognitive function measurement | ATXN2L ASXL1 TNRC6A NOS1 NANOS1 GALNT10 DSCAM PCDHA13 PM20D1 PCDHA8 PCDHA6 PCDHA2 PCDHA1 DERA N4BP2 FURIN SIPA1L1 | 2.05e-04 | 566 | 325 | 17 | EFO_0007660, EFO_0008354 |
| Disease | cortical surface area measurement | MON2 TANC2 CDKN2C ATXN2L DCHS2 CPAMD8 PDE3A DDAH1 DCDC1 DPYSL5 STOX1 SLC26A1 NEO1 TUBA1A TNRC6A TLN2 MAP3K7 ZBTB18 FLNB VRK2 ANK3 BAZ2B FAT3 TUBA1C KHNYN DUT CRPPA NCOR1 TNXB CDH11 | 2.16e-04 | 1345 | 325 | 30 | EFO_0010736 |
| Disease | Epilepsy, Cryptogenic | 2.96e-04 | 82 | 325 | 6 | C0086237 | |
| Disease | Awakening Epilepsy | 2.96e-04 | 82 | 325 | 6 | C0751111 | |
| Disease | Aura | 2.96e-04 | 82 | 325 | 6 | C0236018 | |
| Disease | Colorectal Carcinoma | CPAMD8 ADAM19 CFTR OBSCN GPR87 CSMD3 PTPRD PCDH11X GPNMB CAMSAP2 FAM110B FLNC PMS2 ITPRID1 CDC14A LIG3 TNNI3K TRIM28 TP63 | 3.28e-04 | 702 | 325 | 19 | C0009402 |
| Disease | autosomal dominant intellectual developmental disorder (implicated_via_orthology) | 3.60e-04 | 3 | 325 | 2 | DOID:0060307 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | CDKN2C PDE3A DDAH1 IRF5 ARID5A FNDC1 ASAP2 PTPRD RPTOR TNRC6A SULT6B1 TLN2 FGF9 CORO7 VCL FLNB DSCAM FAT3 PCDHA13 PCDHA8 PCDHA6 PCDHA2 PCDHA1 ADAMTS8 CWC22 LIG3 FURIN CTNNA3 MBD5 RSKR | 3.84e-04 | 1392 | 325 | 30 | EFO_0005763 |
| Disease | pulmonary sarcoidosis (is_marker_for) | 4.07e-04 | 32 | 325 | 4 | DOID:13406 (is_marker_for) | |
| Disease | C-reactive protein measurement | ATXN2L DCHS2 ADAM19 DPYSL5 IRF5 ADARB1 JMY BDNF PTPN2 NEO1 AHNAK SEC16A BSN GCN1 DAGLA ATG16L2 ANK3 YTHDC2 HIF3A IFI16 NCOR1 MARK4 RGS17 TNKS1BP1 DDX20 SNAPC4 IL7R | 4.23e-04 | 1206 | 325 | 27 | EFO_0004458 |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 7.15e-04 | 4 | 325 | 2 | DOID:0070356 (implicated_via_orthology) | |
| Disease | Skin Ulcer | 7.15e-04 | 4 | 325 | 2 | C0037299 | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 7.94e-04 | 38 | 325 | 4 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | Grand Mal Status Epilepticus | 8.68e-04 | 67 | 325 | 5 | C0311335 | |
| Disease | Petit mal status | 8.68e-04 | 67 | 325 | 5 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 8.68e-04 | 67 | 325 | 5 | C0393734 | |
| Disease | Status Epilepticus, Subclinical | 8.68e-04 | 67 | 325 | 5 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 8.68e-04 | 67 | 325 | 5 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 8.68e-04 | 67 | 325 | 5 | C0751523 | |
| Disease | Status Epilepticus | 9.29e-04 | 68 | 325 | 5 | C0038220 | |
| Disease | depressive symptom measurement | CACNA2D2 PHF2 KIRREL3 NOS1 NANOS1 DAGLA VRK2 PCDHA6 PCDHA2 PCDHA1 IHO1 CTNNA3 TNXB | 9.75e-04 | 426 | 325 | 13 | EFO_0007006 |
| Disease | Manic Disorder | 1.13e-03 | 71 | 325 | 5 | C0024713 | |
| Disease | Cleft palate, cleft lip | 1.13e-03 | 279 | 325 | 10 | EFO_0003959, HP_0000175 | |
| Disease | Partial Fetal Alcohol Syndrome | 1.18e-03 | 5 | 325 | 2 | C3661483 | |
| Disease | response to placebo | 1.18e-03 | 5 | 325 | 2 | EFO_0008344 | |
| Disease | mitotic checkpoint serine/threonine-protein kinase BUB1 measurement | 1.18e-03 | 5 | 325 | 2 | EFO_0801806 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 1.18e-03 | 5 | 325 | 2 | C0814154 | |
| Disease | thrombospondin type-1 domain-containing protein 1 measurement | 1.18e-03 | 5 | 325 | 2 | EFO_0802131 | |
| Disease | obsessive-compulsive disorder (is_implicated_in) | 1.18e-03 | 5 | 325 | 2 | DOID:10933 (is_implicated_in) | |
| Disease | urinary microalbumin measurement | 1.31e-03 | 20 | 325 | 3 | EFO_0010967 | |
| Disease | vital capacity | ATXN2L PDE3A CACNA2D2 JMY BDNF DST PTPRD PIK3C2B DAGLA VRK2 DSP POLR2B ZBTB4 PCDHA13 TPRX2 PCDHA8 PCDHA6 PCDHA2 PCDHA1 ADAMTS8 NCOR1 NOP14 CTNNA3 MAPKBP1 SNAPC4 TNXB | 1.32e-03 | 1236 | 325 | 26 | EFO_0004312 |
| Disease | type 1 diabetes mellitus | 1.54e-03 | 242 | 325 | 9 | MONDO_0005147 | |
| Disease | Manic | 1.72e-03 | 78 | 325 | 5 | C0338831 | |
| Disease | Prescription Drug Abuse | 1.76e-03 | 115 | 325 | 6 | C4316881 | |
| Disease | Substance-Related Disorders | 1.76e-03 | 115 | 325 | 6 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.76e-03 | 115 | 325 | 6 | C0029231 | |
| Disease | Drug habituation | 1.76e-03 | 115 | 325 | 6 | C0013170 | |
| Disease | Drug abuse | 1.76e-03 | 115 | 325 | 6 | C0013146 | |
| Disease | Drug Use Disorders | 1.76e-03 | 115 | 325 | 6 | C0013222 | |
| Disease | Drug Dependence | 1.76e-03 | 115 | 325 | 6 | C1510472 | |
| Disease | Substance Dependence | 1.76e-03 | 115 | 325 | 6 | C0038580 | |
| Disease | Substance Use Disorders | 1.76e-03 | 115 | 325 | 6 | C0038586 | |
| Disease | keratoconus (is_implicated_in) | 1.76e-03 | 6 | 325 | 2 | DOID:10126 (is_implicated_in) | |
| Disease | Congenital muscular dystrophy (disorder) | 1.76e-03 | 6 | 325 | 2 | C0699743 | |
| Disease | Curling Ulcer | 1.76e-03 | 6 | 325 | 2 | C0010474 | |
| Disease | 4-androsten-3beta,17beta-diol disulfate 1 measurement | 1.76e-03 | 6 | 325 | 2 | EFO_0021113 | |
| Disease | Alcohol Related Birth Defect | 1.76e-03 | 6 | 325 | 2 | C3146244 | |
| Disease | Duodenal Ulcer | 1.76e-03 | 6 | 325 | 2 | C0013295 | |
| Disease | corneal dystrophy (is_implicated_in) | 1.76e-03 | 6 | 325 | 2 | DOID:2566 (is_implicated_in) | |
| Disease | Depression, Bipolar | 1.82e-03 | 79 | 325 | 5 | C0005587 | |
| Disease | Substance abuse problem | 1.84e-03 | 116 | 325 | 6 | C0740858 | |
| Disease | QRS duration | CDKN2C PTPRD GPR158 ANKRD28 CORO7 MAP3K7 NOTCH2 FAT4 ZBTB4 SIPA1L1 | 1.85e-03 | 298 | 325 | 10 | EFO_0005055 |
| Disease | myopathy (implicated_via_orthology) | 1.92e-03 | 48 | 325 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | hypothyroidism (biomarker_via_orthology) | 1.92e-03 | 80 | 325 | 5 | DOID:1459 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.92e-03 | 80 | 325 | 5 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | CDKN2C FOXQ1 SPAST OBSCN DAP3 LMF2 PTPRD PLA2G4A GPNMB NOS2 NOTCH2 FLNA FLNB SORBS1 PRC1 SPAG6 NCOR1 TRMT2A STPG1 GUCY2F N4BP2 SIPA1L1 GALNT5 | 1.99e-03 | 1074 | 325 | 23 | C0006142 |
| Disease | vitronectin measurement | 1.99e-03 | 23 | 325 | 3 | EFO_0021843 | |
| Disease | suicidal ideation, suicide behaviour | 2.26e-03 | 24 | 325 | 3 | EFO_0004320, EFO_0007623 | |
| Disease | malaria (is_implicated_in) | 2.26e-03 | 24 | 325 | 3 | DOID:12365 (is_implicated_in) | |
| Disease | Allodynia | 2.39e-03 | 84 | 325 | 5 | C0458247 | |
| Disease | Mechanical Allodynia | 2.39e-03 | 84 | 325 | 5 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 2.39e-03 | 84 | 325 | 5 | C0751212 | |
| Disease | Hyperalgesia, Primary | 2.39e-03 | 84 | 325 | 5 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 2.39e-03 | 84 | 325 | 5 | C0751214 | |
| Disease | Tactile Allodynia | 2.39e-03 | 84 | 325 | 5 | C0751213 | |
| Disease | Hyperalgesia | 2.39e-03 | 84 | 325 | 5 | C0020429 | |
| Disease | attention deficit hyperactivity disorder (biomarker_via_orthology) | 2.45e-03 | 7 | 325 | 2 | DOID:1094 (biomarker_via_orthology) | |
| Disease | keratoconus (is_marker_for) | 2.45e-03 | 7 | 325 | 2 | DOID:10126 (is_marker_for) | |
| Disease | Solid Neoplasm | 2.45e-03 | 7 | 325 | 2 | C0280100 | |
| Disease | Nephronophthisis, familial juvenile | 2.45e-03 | 7 | 325 | 2 | C1855681 | |
| Disease | Bleeding tendency | 2.45e-03 | 7 | 325 | 2 | C1458140 | |
| Disease | Grade I Astrocytoma | 2.54e-03 | 25 | 325 | 3 | C1704230 | |
| Disease | interstitial lung disease (is_marker_for) | 2.54e-03 | 25 | 325 | 3 | DOID:3082 (is_marker_for) | |
| Disease | Pilocytic Astrocytoma | 2.54e-03 | 25 | 325 | 3 | C0334583 | |
| Disease | Childhood Cerebral Astrocytoma | 2.54e-03 | 25 | 325 | 3 | C0338070 | |
| Disease | Cerebral Astrocytoma | 2.54e-03 | 25 | 325 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 2.54e-03 | 25 | 325 | 3 | C0750936 | |
| Disease | Astrocytoma | 2.54e-03 | 25 | 325 | 3 | C0004114 | |
| Disease | Subependymal Giant Cell Astrocytoma | 2.54e-03 | 25 | 325 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 2.54e-03 | 25 | 325 | 3 | C0547065 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTKRLAIFPDGTHND | 286 | Q7L211 | |
| RGNKTSPRAHFSVLE | 921 | Q13075 | |
| DPSQDHALAKRSVDG | 501 | P55196 | |
| VGPKSNRGHSVLVDE | 126 | Q5RHP9 | |
| ASDFNKVHLSRRGGI | 816 | Q7Z3E2 | |
| VAVALRKPDGSRHQD | 241 | Q9NRN7 | |
| GAAHSGKRLRAVSPF | 451 | Q03989 | |
| LGPLKGDHSQFTTVR | 221 | Q5SZB4 | |
| DVDTGKLESRLQGPH | 576 | Q8NAA4 | |
| HADTIGSGRAIPIKQ | 111 | Q8TF27 | |
| RKAPENHADTIGSGR | 311 | Q5VTM2 | |
| NHADTIGSGRAIPIK | 316 | Q5VTM2 | |
| SHAGQEEALKPQRAS | 271 | Q6P047 | |
| GKGQDSPLHAVARTA | 196 | Q96DX5 | |
| EPSEGKIKHSGRISF | 476 | P13569 | |
| GVRTHGTLESVNGPK | 36 | P23560 | |
| TPGHGSRQESNFRTK | 3061 | Q7Z407 | |
| EAGRLLQKETHSDGP | 1066 | Q9NY47 | |
| TLTKAPADLRGVAHN | 1201 | P0C0L5 | |
| THAPATLEADRGGKF | 236 | O95433 | |
| TRGSEEGSPKLQHEL | 31 | Q9H013 | |
| FRSDDTKGHPRAVSQ | 416 | Q9UNH5 | |
| AGATNIDVKQRSHPG | 711 | Q9UP79 | |
| SHPAKSLVEQFRGTD | 581 | Q9UIF8 | |
| KEGRRASHTAPQVLF | 186 | O15144 | |
| QVKAIPVEFRGHAGS | 441 | Q5XX13 | |
| FSQKDGSSELPRGHR | 676 | Q9UK96 | |
| AAKRFHDVLGNERPS | 21 | Q14956 | |
| HLVSKGGLDREVTPQ | 201 | Q6V0I7 | |
| SGRNSEKFHIDPLRG | 2506 | Q6V0I7 | |
| IFPNGTIQGTRKDHS | 76 | P31371 | |
| SEKLFQRSIHREPGS | 291 | P28223 | |
| SHLRNSPEDKRAGGE | 96 | Q13541 | |
| KPDDAVLQHATRGSR | 191 | C9J069 | |
| SSGRTPLDLAAFKGH | 581 | O15084 | |
| GASIHDRDAKGETPI | 276 | Q9BZ19 | |
| AREEEPGKFTSRLHN | 761 | P52824 | |
| KAGLRVSAPEVSVGH | 326 | Q09666 | |
| EIFGTQGKPAIAHRD | 316 | P37023 | |
| HGNDAARARFESKVP | 76 | O75689 | |
| DSLPIKRERHGNVAS | 66 | Q9Y5K6 | |
| RAQHLADILSSKGFP | 321 | Q9UHI6 | |
| AKGRTPLHAAAFADN | 856 | Q8NB46 | |
| QIKSLRHGQGFTSTP | 396 | Q6DHV5 | |
| KPFLASLDGHRDGVN | 56 | Q9NV06 | |
| NAENRKATGHSPLEL | 1381 | Q8IXJ9 | |
| KHSAVQRQGSGRESP | 326 | Q8WWM7 | |
| FRGKELQPGSHIQSD | 481 | Q8NE62 | |
| IVPSEQGGALSRHAK | 586 | Q13367 | |
| KRGVNPGEQDSLHTT | 381 | Q5JR59 | |
| AAGHTLTPDREGKEV | 206 | Q8TBN0 | |
| GHGKTPKDAASVRAT | 191 | Q96S59 | |
| PDQSKSRRHDEGNLG | 236 | O43374 | |
| SRQFESLPATHIRGK | 91 | O94776 | |
| KDEFRPNLSHTGRGI | 351 | Q13356 | |
| PDQSKSRRHDEGNLG | 236 | C9J798 | |
| EERGENAGRPTHTTK | 46 | Q9UGC6 | |
| KGRQRQAILGEHPSS | 271 | Q8WVV9 | |
| AHERRFSAGPKVNGT | 166 | P43631 | |
| LFKVRESGSLNPDHG | 196 | P17706 | |
| VTAAKEHGAAGAIRP | 171 | A4D126 | |
| PKGAESGFHVTRIRA | 591 | Q9HCL0 | |
| PEEAKHGTFVGRIAQ | 36 | Q9Y5H9 | |
| PEEAKHGTFVGRIAQ | 36 | Q9UN73 | |
| AASLPHIAKTQRDAG | 116 | Q68EN5 | |
| QERSSFSEHKPRGAL | 606 | Q9HCM3 | |
| DKTPGAVNDGRSHRA | 1431 | Q9HCM3 | |
| KVGSSGDIALHINPR | 226 | P56470 | |
| GEHQRASRIPSQFSK | 31 | Q6GTS8 | |
| QVKAIPVEFRGHAGS | 441 | O95170 | |
| RSAITVFPQRSDGKH | 241 | P35228 | |
| GEVHCGTNVRRKPFS | 641 | Q9UM07 | |
| GHPGSRKFNTTERVL | 12406 | Q8WXI7 | |
| LPEGFTLRRDASNHK | 1711 | Q04721 | |
| AIGHPIRVKAAEGTS | 721 | M0R2J8 | |
| PEEAKHGTFVGRIAQ | 36 | Q9Y5H6 | |
| AASKLVPRSVGAGHV | 576 | Q9Y5H6 | |
| AGVRAETNKGHASPL | 616 | Q96II8 | |
| DKQSRLGLFEISPGH | 36 | Q5T9C9 | |
| LQLPTREAHAKAFGT | 231 | Q6IF63 | |
| ADFIHRALNTPGAKV | 111 | Q6B8I1 | |
| DLHFGSQPEGKFSLR | 101 | Q8TD91 | |
| RKAHPVTNAIDGSER | 111 | Q16787 | |
| ARRKGAASPVLQEDH | 706 | Q8N9B5 | |
| EVGGAAPFNRTHRSK | 106 | P01138 | |
| QERAPGAEVKHRNTS | 901 | Q9HCH0 | |
| GGRKPRDQSHSLVSS | 451 | Q6ZRS4 | |
| PKAGLQSLGSADHRV | 1226 | Q6PRD1 | |
| GNFEHLTEKIRGSPD | 156 | O43824 | |
| AHERRFSAGPKVNGT | 166 | P43628 | |
| RRGPDQHISGSTKDV | 371 | Q5T848 | |
| GHKIPSDRDLVSQGA | 376 | Q8IYA8 | |
| SLQSHIPVLDKGRAG | 7106 | Q03001 | |
| AVAPAAGQGSHSRQK | 46 | Q86SR1 | |
| KNGFLTISHGTANRP | 331 | O43150 | |
| FLHGTKRDDGQASIP | 1266 | Q2LD37 | |
| KSRARALAHGDPFQV | 6 | A9Z1Z3 | |
| LHDPRDTRAGTKGFI | 131 | A9Z1Z3 | |
| GSVPKQLDFQRHGSD | 971 | Q9H252 | |
| RQAHSGPAALQSKAE | 3726 | Q9UPA5 | |
| AQIKPSSGHDRRENL | 6 | Q9HCG8 | |
| RIPSAGERSGHKNLA | 541 | Q96HB5 | |
| ARLGLSTVTGKNHPA | 961 | Q5VYM1 | |
| LLGPSSKFRHAQGTV | 466 | P57737 | |
| SKDPSRLVGQIHDGV | 161 | P43629 | |
| GVERSGLKANEPTHF | 751 | O75369 | |
| HAASGAAAARLLKPE | 196 | Q8WY41 | |
| RHFSVGAPDGKIIAA | 3576 | Q9NYQ8 | |
| EGFGHSTSLKVPLAR | 141 | Q96JN0 | |
| DAARVRDKPVHSGVS | 6 | Q14432 | |
| APREHLGSQLIAGTK | 266 | Q14432 | |
| TPELRCGKHQAVGTS | 891 | P07202 | |
| TKAGFPLAVHSGAAR | 161 | Q9BY49 | |
| PQALTTSQDGHRRKG | 996 | Q5T1M5 | |
| AHDASKVRASGPGLN | 1536 | Q14315 | |
| GHRKTASFGNILDVP | 411 | O43318 | |
| TEAHGARLGPSIEDK | 351 | Q8N3D4 | |
| PGAESHRKNRSIVTN | 661 | P55160 | |
| LLSGHSGFDRPSAVK | 741 | Q14678 | |
| SVNASHGKGFSRPAR | 641 | Q6ZU52 | |
| IHSAGVVHRDLKPGN | 141 | O15264 | |
| LATGKFPVAAERDHV | 296 | Q96LW2 | |
| KHNGPNDASDGTVRL | 6 | P31942 | |
| AHERRFSAGPKVNGT | 166 | Q14952 | |
| RSLDCRESGKNGPHV | 386 | P16871 | |
| KTREAIQHESGILGP | 456 | P00451 | |
| ATASKVDIAPHVRDG | 1741 | Q92616 | |
| HSSEAGKKDVSGPLR | 131 | Q15599 | |
| TRHGPSQDGDNTIFK | 51 | Q13568 | |
| KHGSFLVRESQSHPG | 131 | Q06124 | |
| SIGLPVARQHASSGK | 1471 | Q7Z3U7 | |
| AGKSQRRVTFHLPEG | 1046 | Q9BZA7 | |
| GHVAKSFGLRDAPRN | 741 | Q9H8H2 | |
| KSEAHTADGISIRFP | 791 | P49916 | |
| APRSGLAAKHFIDVG | 171 | P33316 | |
| GSTLVHPFRALGKNS | 631 | P78316 | |
| GDLTDNFSSPHARRK | 336 | P78563 | |
| NFSSPHARRKVLAGV | 341 | P78563 | |
| GDPQRHSQSRASKEG | 1481 | Q08378 | |
| RSDGPGKNTTLHNEF | 26 | Q9BY21 | |
| DGASVRVTPHGLEKV | 176 | Q9BYG4 | |
| TSGAVAFGKQRLRHE | 116 | P54886 | |
| RSAITIFPQRTDGKH | 461 | P29475 | |
| ADFQTAVPGSRKHDL | 606 | O00750 | |
| ITAHDPDEGRNGKVT | 1641 | Q6V1P9 | |
| PEEAKHGTFVGRVAQ | 36 | Q9Y5I3 | |
| PEEAKHGTFVGRIAQ | 36 | Q9Y5I0 | |
| HFSKFIPEGSQRVGL | 461 | P04062 | |
| PAGLSHRRVSGAQKQ | 821 | Q13349 | |
| RASGKHQPSQEGLTL | 2956 | Q5VST9 | |
| PHFIEVRGNGSLTKT | 776 | Q9Y5I4 | |
| APTVNTHFGKLRGAR | 41 | Q9NZ94 | |
| GDGTKRPFRQNTHGI | 371 | Q9H3D4 | |
| TDFTRGKGPLKHTTD | 716 | Q9UI47 | |
| PGSSQVRAHGQKVAD | 51 | P09105 | |
| PGSAQLRAHGSKVVA | 51 | P02008 | |
| AQTVHEDVRAAAGKP | 281 | Q96EP1 | |
| ANPDLKDRTGFAVIH | 61 | P42773 | |
| AQRAATHIPAAGDSK | 26 | Q9HCM4 | |
| PHRDSKDVFILGGTD | 1041 | Q9C0G6 | |
| GPTSVGRKHEFIRSE | 186 | Q6Y7W6 | |
| HQKAAFAITSRRGPT | 976 | O14981 | |
| SDKFHSPARGLQGLA | 586 | Q9BQW3 | |
| TDSNPTLRRNKIHDG | 716 | Q86XK2 | |
| DARALTQTGGPHVKA | 1281 | P21333 | |
| EKHPGFRLTSALNRT | 146 | Q6UUV7 | |
| QDREIKASAHAITGP | 341 | Q05707 | |
| NERAHPASTAVPKSG | 236 | Q7Z7M9 | |
| ERAVGSLHPKGAFAQ | 651 | Q4ZHG4 | |
| LARLDAEKAHAASPG | 396 | Q495W5 | |
| GPAVANSVARKHGFL | 41 | P09958 | |
| GSTDKARHFLESAAP | 1291 | Q8IZJ3 | |
| QIATGGIIDPKESHR | 2371 | P15924 | |
| EDVTFINPHFGSKRG | 511 | P51841 | |
| INPHFGSKRGSRASV | 516 | P51841 | |
| QGVSEERIHLGSSPK | 46 | Q9H410 | |
| AGTKVIHVRATDGDP | 2511 | Q8TDW7 | |
| RPRNGTLNKHSGIDF | 176 | Q13418 | |
| DAGRRHVSGKPDTQE | 2061 | Q3T8J9 | |
| GNKTPAEVSHRFREL | 2186 | Q3T8J9 | |
| VAKEAAPEASRHLGA | 66 | Q8IX06 | |
| AAAGTVVGRVHAKDP | 396 | P55287 | |
| VVGRVHAKDPDAANS | 401 | P55287 | |
| VPGSEFEGHKRISEQ | 1021 | Q7Z591 | |
| QKSGAQFFTLEGRHP | 3496 | Q12955 | |
| DSKGRDHLSGVPTDV | 251 | Q9BSJ5 | |
| VTGKESQGERPHLSL | 341 | Q9BSJ5 | |
| LVGTASNPHEARKVN | 146 | Q9Y2A9 | |
| SAHRIITDSKQPFGD | 236 | Q92611 | |
| APKSGNTGELRSVIH | 741 | Q16666 | |
| HQGLSSPVTKSFNRG | 91 | P01834 | |
| ETLRPHVVGSGGNDK | 666 | Q7KZI7 | |
| SGSLPFDGHNLKELR | 251 | Q96L34 | |
| GPRKHGQEALETSLT | 896 | O60336 | |
| QRLGSSEHGQKSPFR | 201 | Q9P267 | |
| GHGASPAKQDELVIS | 1026 | Q9Y4D2 | |
| RALGSPTLKVFGNHA | 91 | Q8TC76 | |
| RTQGSSKAQHPSRGF | 596 | O15037 | |
| PASGREGEEHSTIKQ | 586 | Q8IZU9 | |
| EELSFVAGAPRANHK | 321 | Q13683 | |
| GNPTVEVDLHTAKGR | 16 | P13929 | |
| TNFSEKDRPENVHGG | 276 | Q14527 | |
| PRNHFGVGRSTVTTK | 216 | Q9Y4K1 | |
| NARGHEVTLVSRKPG | 21 | Q9NRG7 | |
| QDRSVGHSRIPSAKG | 51 | Q9NQC7 | |
| ESEARTPFGLIKGHA | 241 | O14815 | |
| AAGFPAGQTHLKTRL | 126 | Q9Y315 | |
| FLRVFGHSKANGEPT | 606 | Q9UHW9 | |
| NARGSFVHSVKPGSL | 686 | Q9BXL7 | |
| TGDNESVHSGKRTPR | 1296 | Q08AD1 | |
| RGERPHSFGSNAVNK | 31 | P07358 | |
| LPESLGQHALRSAKG | 21 | O94760 | |
| GSHRQGKDNLERDPS | 21 | Q9H2S9 | |
| SGSQIDDHVPKRASA | 536 | Q9BPU6 | |
| FVPRAAHGDKQGSDL | 6 | Q9C009 | |
| GKEFGVERSVRPIHS | 961 | P46019 | |
| SAGGLQHRVTAKTAP | 1091 | P23468 | |
| GRIKTNGSPTEHLTE | 336 | O14829 | |
| KNSEGLHSARDVPVV | 176 | P47712 | |
| SALFNTREGRAGKVH | 476 | P47712 | |
| AHERRLPAGTKVNGT | 166 | Q14954 | |
| VAGTTGIAHRDLKPE | 201 | Q9BUB5 | |
| RSRKPGAVIESFVNH | 261 | Q504T8 | |
| ANSAPSILDGFDHRK | 221 | O60469 | |
| KAQLGDSRLSPDVGH | 511 | Q9BVN2 | |
| LIVAHFGTSRDPGVK | 1006 | Q8N2Y8 | |
| RAISRTNENDPAKHG | 46 | P51398 | |
| GRAPLRQFEGHTKAV | 111 | Q8TED0 | |
| HRIGAPGVEEIKSNS | 366 | Q15208 | |
| SQDTHGAVGPFLFRK | 246 | Q6IMI4 | |
| KTSLAQHFTAGPGRA | 346 | Q8IZ69 | |
| VHRTAGQKDSEPLGI | 231 | O95602 | |
| DPFSSKHNVIVGRNG | 21 | Q9UQE7 | |
| PHDSKARRLFVTSGG | 441 | O75602 | |
| VEQATKPSFERGRHG | 81 | Q96E39 | |
| FTEGKVPHIRIENGA | 96 | Q9BYT3 | |
| EGSLHIDTDTKPGRN | 736 | O75151 | |
| VTTQKLEAHRGEAGP | 666 | Q6ZMZ3 | |
| RKPALTAIEGTAHGE | 111 | Q9UBV2 | |
| ASHRKEAPQGRQAGA | 146 | Q9BU23 | |
| SQARAGKAEGTAPLH | 326 | O94761 | |
| PSNGHFSTKIEIRQG | 1076 | Q9P2J5 | |
| SRTNGTIHFGVKDKP | 231 | Q8IVG5 | |
| STFGLQDGNLRAPHK | 51 | Q9BRQ6 | |
| SDQLLGFPLHKSRAG | 201 | Q5QGS0 | |
| IEGKLQRGSPTDFAH | 41 | O43320 | |
| QRGSPTDFAHLKGIL | 46 | O43320 | |
| LPFARGVSAHLDKAS | 41 | Q9Y2N7 | |
| SKDPSRLVGQIHDGV | 161 | Q14943 | |
| SPEKGREEAASKGHV | 1196 | O75376 | |
| HNKLSDEGLPSRGFD | 246 | O60938 | |
| QNKHGSGESSAPLRV | 516 | Q92859 | |
| TPRTGRHGANKENLE | 536 | O43663 | |
| VRIPQIGDKFASRHG | 926 | P30876 | |
| DRASVVGTDGTPKVH | 16 | O43166 | |
| AEKGLGTQAPHTVLR | 681 | Q8N196 | |
| HSTRGILGSQEPDFK | 46 | Q07837 | |
| AVDGGLSIPHSTKRF | 166 | P46777 | |
| GAATDHADKNGRTPL | 1156 | Q9HCD6 | |
| EAHLPSSTAGQRRKQ | 256 | Q96NU1 | |
| FDRHGQKRSEINLPG | 41 | Q8NEZ3 | |
| HSPGKELQHRTRAEA | 6 | Q5H9E4 | |
| RNGHLQSESGAVPKR | 221 | Q9UBP0 | |
| DSGRPHSRAVFNETK | 681 | P11215 | |
| RSGFPRDKLAELHGN | 121 | Q8N6T7 | |
| NTPSGKVQEDTHGRF | 206 | Q96PQ1 | |
| AGEVTFADAHRPKLN | 131 | Q13243 | |
| KRPDGHIVSVSVNGD | 1221 | Q8N122 | |
| SRNSLGEGQEPKSHL | 486 | Q9Y4F9 | |
| FQTTIPHGKSQREGR | 286 | Q9Y2K9 | |
| HGRGNFPTLEITLKD | 36 | Q5VWP2 | |
| PEEVKHATLRFNGTR | 701 | Q8TER0 | |
| HVGSPFALGANKDSL | 496 | Q9UPX8 | |
| SVPIEHGFRRQQSKS | 891 | Q9UK61 | |
| DSGAKIASNPLERHV | 1106 | Q9UK61 | |
| RKAPENHADTIGSGR | 266 | A6NIR3 | |
| NHADTIGSGRAIPIK | 271 | A6NIR3 | |
| IKFGGHPLRSAESDQ | 101 | Q6ZVT6 | |
| VDRKVSQPIEGHAAS | 186 | Q00610 | |
| DHVKSGNITARDPAI | 436 | Q9NQ89 | |
| SGEQPSGGRIHNLKT | 101 | Q6X4T0 | |
| LPFHVDNSASGKRVN | 841 | Q70EK8 | |
| EPDAGRIHAGSKTAK | 346 | Q8NFZ5 | |
| GKAFSSGSDLIRHQR | 561 | Q5HYK9 | |
| VGSSSPRNGLQDKHL | 166 | Q5SXH7 | |
| SARQETKKVHPGAGA | 331 | Q9NZR4 | |
| TGAGKHVPRAVFVDL | 56 | P0DPH8 | |
| LNGAKTGVFSTRSPH | 106 | Q9BU70 | |
| QGSSRRHLGDAFKPD | 501 | Q13114 | |
| KILQGSFPLGDSRSH | 296 | A0A0J9YY54 | |
| GHRGFVPEKNFRVTA | 511 | Q9Y2W1 | |
| GDSAVGRHRKVSPNC | 76 | P98170 | |
| PAGKGHSVRNVQAFA | 371 | Q8IZQ1 | |
| FSHRALQGTIAKNPE | 301 | Q99797 | |
| AVAREESGKPGAHVT | 96 | P22626 | |
| SHLVGVKPFEADRAN | 616 | O15027 | |
| LHKRFGSSVAGDIPT | 311 | Q9H2B4 | |
| QHLSGERGHKSRPTF | 31 | C9JQI7 | |
| KRISNPFQGLSHRGS | 491 | Q6ZVD7 | |
| TGKHPRRASEVQKGF | 11 | Q5TH74 | |
| PEKLEHFQEASGTRG | 706 | Q9NS62 | |
| THFREQDGIRSKPAA | 391 | Q99592 | |
| SNFHAVKRESDGAPG | 656 | Q9BX66 | |
| EAKGDAHLRPTSLVQ | 411 | Q9C0C2 | |
| LRGPHKADSIQGTAR | 3736 | P22105 | |
| TGAGKHVPRAVFVDL | 56 | P0DPH7 | |
| PAIEHGRRSNVLGDK | 241 | P58340 | |
| GFTQGHQTKPLRAEI | 1601 | P24821 | |
| VANSRPAKAAVHLEG | 481 | P18206 | |
| ESALHAGEKAPRAQL | 186 | A0A1W2PR48 | |
| HEPGRAGTIKENSRC | 166 | Q8IWV7 | |
| AGDTKFPAHRSVLAA | 36 | Q9P1Z0 | |
| SHSADPKLVEARFRG | 71 | Q9BZZ2 | |
| AGSRIADGLPVAVKH | 56 | Q86V86 | |
| ASGFKGQRPETLHER | 126 | Q5BJF2 | |
| TGFHTKKIVRGPASD | 2056 | O00507 | |
| GPHKADSIQGTARTL | 226 | Q16473 | |
| EDDSTKHGGRVRTFP | 61 | Q9BQ65 | |
| GVLRPQKEAVSSSHG | 466 | P54278 | |
| HGASVNAKDVDGRTP | 156 | Q9BZF9 | |
| KRFSHSGNQLDGPIT | 36 | O60844 | |
| LSRVDDAVAAKHPGL | 6 | Q96I45 | |
| VDRSPFAKSLGHSRG | 1111 | Q641Q2 | |
| GILHPKRGTEDRSDQ | 1236 | Q9H6S0 | |
| GAQERALDHRKPSTS | 31 | Q09FC8 | |
| LSRSQGAEEKRQHPG | 216 | P20396 | |
| RTGKAEHGSVALPAV | 441 | Q9Y4G6 | |
| VPAVSAAVKGLRSHE | 1996 | Q96JM2 | |
| KASSRRGGDHVALQP | 436 | Q9ULC8 | |
| HSADTRPAGAEKQAL | 646 | Q5SXM2 | |
| HKATSLVVGGEAERP | 1326 | Q5SXM2 | |
| TGAGKHVPRAVFVDL | 56 | Q71U36 | |
| GQEDHKDTSRIPARF | 171 | A2RU30 | |
| TGAGKHVPRAVFVDL | 56 | Q6PEY2 | |
| TGAGKHVPRAVFVDL | 56 | P68363 | |
| ALGAHLEAEPKSQRS | 496 | Q9NUQ3 | |
| SGEVGDRPLHLASAK | 196 | Q59H18 | |
| PVGRSAVGHVFSLEK | 806 | Q69YN4 | |
| PGGLQHETQELASKR | 51 | Q00577 | |
| TGAGKHVPRAVFVDL | 56 | Q9BQE3 | |
| TQKAATGPFDREHLL | 56 | Q9NZR1 | |
| GPRASEALHTKAVFQ | 61 | O95932 | |
| KHGAISSGFRLEESP | 1556 | Q8NDV7 | |
| GKQRAAGSPHLTLEF | 256 | Q96GM8 | |
| VLAKGDHSPVTRAAA | 911 | Q9H3U1 | |
| PRKGHNGTIEFTSLD | 206 | Q86Y07 | |
| TGAGRKHSNFLRLSD | 81 | Q8TD43 | |
| GRPSFVNDSVHLAKR | 131 | P17021 | |
| TKFQRTSPEGGIHLS | 576 | Q14202 | |
| SVRFRKPLFGETGHT | 1091 | O95405 | |
| TGAGKHVPRAVFVDL | 56 | P68366 | |
| GFVDKNHSVPRSLLD | 286 | P0DV77 | |
| ASIPGSEVKLRDAAH | 1266 | O75962 | |
| ITDISPKQSTHGERG | 331 | Q9Y2L8 | |
| VEAILNHPGFAASKR | 106 | Q13507 | |
| AEPHVSGVKRSRSGE | 461 | Q13263 | |
| QGTSGKEHLRVNSPA | 101 | Q8IZ26 | |
| QGRTTAHKDPNAIFL | 136 | P40225 | |
| GDKGNFSVHSAVVPR | 11 | Q7RTS7 | |
| TAVAHRPGAFKAELS | 146 | Q969H8 | |
| PDAQAVKHFRAGRDS | 421 | Q8N145 | |
| PGSGKTTLARQLQHD | 51 | Q5TBK1 | |
| LTSGQPFHKLRAQVG | 676 | Q8N9H8 | |
| RGSPHESVEDGRKSQ | 841 | Q86UW6 | |
| VSALHGAVPARFQKD | 1431 | Q13224 | |
| LGHHVGFRSLQDDPK | 2316 | P20929 |